- Overview
-
The goal of my research is to develop new treatments for patients with rare diseases. One strategy that we are working on is to develop new gene therapies. Another approach that we are working on is to understand why certain patients respond positively to a medication, while others receive no benefit, or worse, develop debilitating or life-threatening adverse drug reactions (ADRs) to the same dose of medication. We work collaboratively with clinicians and researchers from across Canada and around the world.
1. We successfully developed the first gene therapy to achieve regulatory approval. That work has led to many new gene therapies coming onto the market and many more in development. We are now working on several approaches to reduce the high costs of gene therapies by developing more efficient products and improved manufacturing.
2. We are developing new approaches for gene therapy that utilize genome editing for improved effectiveness and reduced costs.
3. We have recruited patients that have suffered specific serious ADRs, as well as control patients that have recived the same drugs without ADRs. We use high-throughput genomics and next-generation DNA sequencing technologies to identify the genetic factors of severe ADRs of key clinical importance.
The research involves many approaches from statistical, computational and molecular genetics, to molecular biology, and cell biology. The program’s mission is to translate these findings into new diagnostics and therapeutics that will improve the quality of lives of patients and families.
- Publications
-
Machine learning model identifies genetic predictors of cisplatin-induced ototoxicity in CERS6 and TLR4
Computers in Biology and Medicine
Ali Arab and Bahareh Kashani and Miguel Cordova-Delgado and Erika N. Scott and Kaveh Alemi and Jessica Trueman and Gabriella Groeneweg and Wan-Chun Chang and Catrina M. Loucks and Colin J.D. Ross and Bruce C. Carleton and Martin Ester
DOI: 10.1016/j.compbiomed.2024.109324
12/2024Genomic variations associated with risk and protection against vincristine-induced peripheral neuropathy in pediatric cancer patients
npj Genomic Medicine
Kheireddin Mufti and Miguel Cordova and Erika N. Scott and Jessica N. Trueman and Jessica M. Lovnicki and Catrina M. Loucks and Shahrad R. Rassekh and Colin J. D. Ross and Bruce C. Carleton and Gabriella S. S. Groeneweg and Michelle Higginson and Wan-Chun Chang and Kathy Li and Fudan Miao and Derek Yau and Lucie Pecheux and Bina Gyawali and Amanda Perreault and Fatema Abbasi and Gregory Guilcher and Gesche Riabowol and Geert ’t Jong and Michelle Staub and Geoff Cuvelier and Kathleen Felton and Sara Khalaj and Michael Rieder and Awatif Abuzgaia and Tamorah Lewis and Himal Ghimire and Paul Nathan and Donna Johnston and Mounira Ibrahim and Jean-François Bussières and Thaïna-Rafi Jean-Baptiste and Denis Lebel and Maja Krajinovic and Thai Hoa Tran and Kerry Goralski and Zara Forbrigger and Ketan Kulkarni
DOI: 10.1038/s41525-024-00443-7
11/2024Supplementary Fig. 1 from INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin JD. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.27031420
09/2024Supplementary Fig. 5 from INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin JD. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.27031408.v1
09/2024Supplementary Fig. 4 from INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin JD. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.27031411
09/2024Data from INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin JD. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.c.6664582.v3
09/2024Supplementary Data 1 from INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin JD. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.27031423
09/2024Supplementary Fig. 3 from INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin JD. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.27031414
09/2024Supplementary Fig. 2 from INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin JD. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.27031417
09/2024The Role of Pharmacogenomics in Rare Diseases
Drug Safety
Man, A. and Groeneweg, G.S.S. and Ross, C.J.D. and Carleton, B.C.
DOI: 10.1007/s40264-024-01416-6
2024Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin
Pediatric Nephrology
Chui, H. and McMahon, K.R. and Rassekh, S.R. and Schultz, K.R. and Blydt-Hansen, T.D. and Mammen, C. and Pinsk, M. and Cuvelier, G.D.E. and Carleton, B.C. and Tsuyuki, R.T. and Ross, C.J.D. and Devarajan, P. and Huynh, L. and Yordanova, M. and Crépeau-Hubert, F. and Wang, S. and Cockovski, V. and Palijan, A. and Zappitelli, M.
DOI: 10.1007/s00467-023-06007-8
2024Systemic delivery of proteins using novel peptides via the sublingual route
Journal of Controlled Release
Wu, J. and Jones, N. and Hohenwarter, L. and Zhao, F. and Chan, V. and Tan, Z. and Carlaw, T. and Morin, T. and Li, J. and Kaur, T. and Andrew, L.J. and Ross, C.J.D. and Hedtrich, S. and Li, S.-D.
DOI: 10.1016/j.jconrel.2024.02.042
2024CIAO1 and MMS19 deficiency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders
Genetics in Medicine
van Karnebeek, C.D.M. and Tarailo-Graovac, M. and Leen, R. and Meinsma, R. and Correard, S. and Jansen-Meijer, J. and Prykhozhij, S.V. and Pena, I.A. and Ban, K. and Schock, S. and Saxena, V. and Pras-Raves, M.L. and Drögemöller, B.I. and Grootemaat, A.E. and van der Wel, N.N. and Dobritzsch, D. and Roseboom, W. and Schomakers, B.V. and Jaspers, Y.R.J. and Zoetekouw, L. and Roelofsen, J. and Ferreira, C.R. and van der Lee, R. and Ross, C.J. and Kochan, J. and McIntyre, R.L. and van Klinken, J.B. and van Weeghel, M. and Kramer, G. and Weschke, B. and Labrune, P. and Willemsen, M.A. and Riva, D. and Garavaglia, B. and Moeschler, J.B. and Filiano, J.J. and Ekker, M. and Berman, J.N. and Dyment, D. and Vaz, F.M. and Wassermann, W.W. and Houtkooper, R.H. and van Kuilenburg, A.B.P.
DOI: 10.1016/j.gim.2024.101104
2024Supplementary Fig. 2 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin J.D. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.23627144
07/2023Supplementary Fig. 4 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin J.D. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.23627138
07/2023Supplementary Data 1 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin J.D. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.23627150
07/2023Data from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin J.D. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.c.6664582.v2
07/2023Supplementary Fig. 1 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin J.D. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.23627147
07/2023Supplementary Fig. 3 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin J.D. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.23627141
07/2023Supplementary Fig. 5 from Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Etan Orgel and Kristin R. Knight and Yueh-Yun Chi and Jemily Malvar and Teresa Rushing and Victoria Mena and Laurie S. Eisenberg and Shahrad R. Rassekh and Colin J.D. Ross and Erika N. Scott and Michael Neely and Edward A. Neuwelt and Leslie L. Muldoon and David R. Freyer
DOI: 10.1158/1078-0432.23627135
07/2023Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
Frontiers in Pharmacology
Wu, A. and Anderson, H. and Hughesman, C. and Young, S. and Lohrisch, C. and Ross, C.J.D. and Carleton, B.C.
DOI: 10.3389/fphar.2023.1257745
2023RBL2 Regulates Cardiac Sensitivity to Anthracycline Chemotherapy
JACC: CardioOncology
Xia, P. and Chen, J. and Sapkota, Y. and Scott, E.N. and Liu, Y. and Hudson, M.M. and Rassekh, S.R. and Carleton, B.C. and Ross, C.J.D. and Chow, E.J. and Cheng, Z.
DOI: 10.1016/j.jaccao.2022.10.017
2023A luciferase reporter mouse model to optimize in vivo gene editing validated by lipid nanoparticle delivery of adenine base editors
Molecular Therapy
Yu, S.-Y. and Carlaw, T. and Thomson, T. and Birkenshaw, A. and Basha, G. and Kurek, D. and Huang, C. and Kulkarni, J. and Zhang, L.-H. and Ross, C.J.D.
DOI: 10.1016/j.ymthe.2023.02.009
2023Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity
Therapeutic Drug Monitoring
Siemens, A. and Rassekh, S.R. and Ross, C.J.D. and Carleton, B.C.
DOI: 10.1097/FTD.0000000000001077
2023Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study
Pediatric Nephrology
McMahon, K.R. and Lebel, A. and Rassekh, S.R. and Schultz, K.R. and Blydt-Hansen, T.D. and Cuvelier, G.D.E. and Mammen, C. and Pinsk, M. and Carleton, B.C. and Tsuyuki, R.T. and Ross, C.J.D. and Huynh, L. and Yordanova, M. and Crépeau-Hubert, F. and Wang, S. and Palijan, A. and Lee, J. and Boyko, D. and Zappitelli, M.
DOI: 10.1007/s00467-022-05745-5
2023Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update
Therapeutic Drug Monitoring
Scott, E.N. and Joseph, A.A. and Dhanda, A. and Tanoshima, R. and Brooks, B. and Rod Rassekh, S. and Ross, C.J.D. and Carleton, B.C. and Loucks, C.M.
DOI: 10.1097/FTD.0000000000001113
2023Preclinical Development and Characterization of Novel Adeno-Associated Viral Vectors for the Treatment of Lipoprotein Lipase Deficiency
Human Gene Therapy
Mehta, N. and Gilbert, R. and Chahal, P.S. and Moreno, M.J. and Nassoury, N. and Coulombe, N. and Lytvyn, V. and Mercier, M. and Fatehi, D. and Lin, W. and Harvey, E.M. and Zhang, L.-H. and Nazemi-Moghaddam, N. and Elahi, S.M. and Ross, C.J.D. and Stanimirovic, D.B. and Hayden, M.R.
DOI: 10.1089/hum.2023.075
2023Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone
Pain Reports
Ali, S. and Yukseloglu, A. and Ross, C.J. and Rosychuk, R.J. and Drendel, A.L. and Manaloor, R. and Johnson, D.W. and Le May, S. and Carleton, B.
DOI: 10.1097/PR9.0000000000001113
2023Generation of a human induced pluripotent stem cell line from a patient with hypomyelinating leukodystrophy 22 (HLD22)
Stem Cell Research
Ozgoren, O.K. and Sequiera, G.L. and Ferrari Bardile, C. and Gjervan, S.C. and Salman, A. and Lehman, A. and Turvey, S.E. and Ross, C.J.D. and Stockler, S. and Pouladi, M.A.
DOI: 10.1016/j.scr.2023.103174
2023Association Between HLA–DPB1 and Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in Children
Arthritis and Rheumatology
Gibson, K.M. and Drögemöller, B.I. and Foell, D. and Benseler, S.M. and Graham, J. and Hancock, R.E.W. and Luqmani, R.A. and Cabral, D.A. and Brown, K.L. and Ross, C.J.
DOI: 10.1002/art.42423
2023Noninvasive testing for mycophenolate exposure in children with renal transplant using urinary metabolomics
Pediatric Transplantation
Taha, K. and Sharma, A. and Kroeker, K. and Ross, C. and Carleton, B. and Wishart, D. and Medeiros, M. and Blydt-Hansen, T.D.
DOI: 10.1111/petr.14460
2023Lipid Nanoparticle-Mediated Hit-and-Run Approaches Yield Efficient and Safe In Situ Gene Editing in Human Skin
ACS Nano
Bolsoni, J. and Liu, D. and Mohabatpour, F. and Ebner, R. and Sadhnani, G. and Tafech, B. and Leung, J. and Shanta, S. and An, K. and Morin, T. and Chen, Y. and Arguello, A. and Choate, K. and Jan, E. and Ross, C.J. and Brambilla, D. and Witzigmann, D. and Kulkarni, J. and Cullis, P.R. and Hedtrich, S.
DOI: 10.1021/acsnano.3c08644
2023Human ASXL1 Deficiency Causes Epigenetic Dysfunction, Combined Immunodeficiency and EBV–Associated Hodgkin Lymphoma
medRxiv
Fu, M.P. and Sharma, M. and Merrill, S.M. and Yousefi, P. and Tan, R. and Modi, B.P. and Bel, K.D. and Deyell, R.J. and Rozmus, J. and Rehmus, W. and Hildebrand, K.J. and James, E. and Blanchard-Rohner, G. and Lin, S. and Shopsowitz, K.E. and Setiadi, A. and Terry, J. and Lee, A.F. and Drögemöller, B.I. and Matthews, A. and Tarailo-Graovac, M. and Sauvé, L. and Mitchell, H. and Prendiville, J.S. and MacIsaac, J.L. and Dever, K. and Lin, D.T.S. and Meijer, M. and Ross, C.J.D. and Dobson, S.R.M. and Vercauteren, S.M. and Wasserman, W.W. and van Karnebeek, C.D.M. and McKinnon, M.L. and Kobor, M.S. and Turvey, S.E. and Biggs, C.M.
DOI: 10.1101/2023.12.20.23300096
2023Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children
Therapeutic Drug Monitoring
Siemens, A. and Brooks, B. and Rassekh, S.R. and Meijer, A.J.M. and Van Den Heuvel-Eibrink, M.M. and Xu, W. and Loucks, C.M. and Ross, C.J.D. and Carleton, B.C.
DOI: 10.1097/FTD.0000000000001085
2023Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Clinical cancer research : an official journal of the American Association for Cancer Research
Orgel, E. and Knight, K.R. and Chi, Y.-Y. and Malvar, J. and Rushing, T. and Mena, V. and Eisenberg, L.S. and Rassekh, S.R. and Ross, C.J.D. and Scott, E.N. and Neely, M. and Neuwelt, E.A. and Muldoon, L.L. and Freyer, D.R.
DOI: 10.1158/1078-0432.CCR-23-0252
2023Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
Molecular Pharmaceutics
Kazemian, P. and Yu, S.-Y. and Thomson, S.B. and Birkenshaw, A. and Leavitt, B.R. and Ross, C.J.D.
DOI: 10.1021/acs.molpharmaceut.1c00916
2022Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity
Circulation
Magdy, T. and Jouni, M. and Kuo, H.-H. and Weddle, C.J. and Lyra-Leite, D. and Fonoudi, H. and Romero-Tejeda, M. and Gharib, M. and Javed, H. and Fajardo, G. and Ross, C.J.D. and Carleton, B.C. and Bernstein, D. and Burridge, P.W.
DOI: 10.1161/CIRCULATIONAHA.121.055801
2022A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women
Biomedicine and Pharmacotherapy
Drögemöller, B.I. and Wright, G.E.B. and Trueman, J. and Shaw, K. and Staub, M. and Chaudhry, S. and Miao, F. and Higginson, M. and Groeneweg, G.S.S. and Brown, J. and Magee, L.A. and Whyte, S.D. and West, N. and Brodie, S.M. and Jong, G.?. and Israels, S. and Berger, H. and Ito, S. and Rassekh, S.R. and Sanatani, S. and Ross, C.J.D. and Carleton, B.C.
DOI: 10.1016/j.biopha.2022.112684
2022Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney Injury
Kidney360
Mcmahon, K.R. and Chui, H. and Rassekh, S.R. and Schultz, K.R. and Blydt-Hansen, T.D. and Mammen, C. and Pinsk, M. and Cuvelier, G.D.E. and Carleton, B.C. and Tsuyuki, R.T. and Ross, C.J.D. and Devarajan, P. and Huynh, L. and Yordanova, M. and Crépeau-Hubert, F. and Wang, S. and Cockovski, V. and Palijan, A. and Zappitelli, M.
DOI: 10.34067/KID.0004802021
2022The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments
Cancer
Meijer, A.J.M. and Li, K.H. and Brooks, B. and Clemens, E. and Ross, C.J. and Rassekh, S.R. and Hoetink, A.E. and van Grotel, M. and van den Heuvel-Eibrink, M.M. and Carleton, B.C.
DOI: 10.1002/cncr.33848
2022Experiences with Genetic Counseling, Testing, and Diagnosis among Adolescents with a Genetic Condition: A Scoping Review
JAMA Pediatrics
Wainstein, T. and Marshall, S.K. and Ross, C.J.D. and Virani, A.K. and Austin, J.C. and Elliott, A.M.
DOI: 10.1001/jamapediatrics.2021.4290
2022Assessing the role of adolescent hormonal contraceptive use on risk for depression: a 3-year longitudinal study protocol
BMC Women's Health
Zareian, B. and Anderl, C. and LeMoult, J. and Galea, L.A.M. and Prior, J.C. and Rights, J.D. and Ross, C.J. and Ge, S. and Hayward, A.C. and Chen, F.S.
DOI: 10.1186/s12905-022-01623-2
2022All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity
PLoS ONE
Hasbullah, J.S. and Scott, E.N. and Bhavsar, A.P. and Gunaretnam, E.P. and Miao, F. and Soliman, H. and Carleton, B.C. and Ross, C.J.D.
DOI: 10.1371/journal.pone.0276541
2022Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients
Pharmacogenomics
Vargas-Neri, J.L. and Carleton, B. and Ross, C.J. and Medeiros, M. and Castañeda-Hernández, G. and Clark, P.
DOI: 10.2217/pgs-2021-0144
2022Patient-specific genetic factors predict treatment failure in sofosbuvir-treated patients with chronic hepatitis C
Liver International
Loucks, C.M. and Lin, J.J. and Trueman, J.N. and Drögemöller, B.I. and Wright, G.E.B. and Chang, W.-C. and Li, K.H. and Yoshida, E.M. and Ford, J.-A. and Lee, S.S. and Crotty, P. and Kim, R.B. and Al-Judaibi, B. and Schwarz, U.I. and Ramji, A. and Farivar, J.F. and Tam, E. and Walston, L.L. and Ross, C.J.D. and Carleton, B.C.
DOI: 10.1111/liv.15175
2022Increasing the Targeting Scope of CRISPR Base Editing System beyond NGG
CRISPR Journal
Yu, S.-Y. and Birkenshaw, A. and Thomson, T. and Carlaw, T. and Zhang, L.-H. and Ross, C.J.D.
DOI: 10.1089/crispr.2021.0109
2022A Systematic Review of Polygenic Models for Predicting Drug Outcomes
Journal of Personalized Medicine
Siemens, A. and Anderson, S.J. and Rassekh, S.R. and Ross, C.J.D. and Carleton, B.C.
DOI: 10.3390/jpm12091394
2022A cross-sectional study of the relationship between CYP2D6 and CYP2C19 variations and depression symptoms, for women taking SSRIs during pregnancy
Archives of Women's Mental Health
Hippman, C. and Slomp, C. and Morris, E. and Batallones, R. and Inglis, A. and Carrion, P. and Brain, U. and Higginson, M. and Wright, G.E.B. and Balneaves, L.G. and Ryan, D. and Nislow, C. and Ross, C.J.D. and Gaedigk, A. and Oberlander, T.F. and Austin, J.
DOI: 10.1007/s00737-021-01149-w
2022Pharmacogenetic testing to guide therapeutic decision-making and improve outcomes for children undergoing anthracycline-based chemotherapy
Basic and Clinical Pharmacology and Toxicology
Loucks, C.M. and Yan, K. and Tanoshima, R. and Ross, C.J.D. and Rassekh, S.R. and Carleton, B.C.
DOI: 10.1111/bcpt.13593
2022Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study
Journal of Personalized Medicine
Zazuli, Z. and de Jong, C. and Xu, W. and Vijverberg, S.J.H. and Masereeuw, R. and Patel, D. and Mirshams, M. and Khan, K. and Cheng, D. and Ordonez-Perez, B. and Huang, S.H. and Spreafico, A. and Hansen, A.R. and Goldstein, D.P. and de Almeida, J.R. and Bratman, S.V. and Hope, A. and Knox, J.J. and Wong, R.K.S. and Darling, G.E. and Kitchlu, A. and van Haarlem, S.W.A. and van der Meer, F. and van Lindert, A.S.R. and Heuvel, A.T. and Brouwer, J. and Ross, C.J.D. and Carleton, B.C. and Egberts, T.C.G. and Herder, G.J.M. and Deneer, V.H.M. and Maitland-Van der Zee, A.H. and Liu, G.
DOI: 10.3390/JPM11111233
2021TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
npj Precision Oncology
Meijer, A.J.M. and Diepstraten, F.A. and Langer, T. and Broer, L. and Domingo, I.K. and Clemens, E. and Uitterlinden, A.G. and de Vries, A.C.H. and van Grotel, M. and Vermeij, W.P. and Ozinga, R.A. and Binder, H. and Byrne, J. and van Dulmen-den Broeder, E. and Garrè, M.L. and Grabow, D. and Kaatsch, P. and Kaiser, M. and Kenborg, L. and Winther, J.F. and Rechnitzer, C. and Hasle, H. and Kepak, T. and Kepakova, K. and Tissing, W.J.E. and van der Kooi, A.L.F. and Kremer, L.C.M. and Kruseova, J. and Pluijm, S.M.F. and Kuehni, C.E. and van der Pal, H.J.H. and Parfitt, R. and Spix, C. and Tillmanns, A. and Deuster, D. and Matulat, P. and Calaminus, G. and Hoetink, A.E. and Elsner, S. and Gebauer, J. and Haupt, R. and Lackner, H. and Blattmann, C. and Neggers, S.J.C.M.M. and Rassekh, S.R. and Wright, G.E.B. and Brooks, B. and Nagtegaal, A.P. and Drögemöller, B.I. and Ross, C.J.D. and Bhavsar, A.P. and am Zehnhoff-Dinnesen, A.G. and Carleton, B.C. and Zolk, O. and van den Heuvel-Eibrink, M.M. and de Vries, A.C.H. and van Grotel, M. and van Dulmen-den Broeder, E. and van der Kooi, A.L.F. and Kremer, L.C.M. and van der Pal, H.J.H. and Calaminus, G.
DOI: 10.1038/s41698-021-00178-z
2021Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects
Neurogenetics
van Karnebeek, C.D. and Blydt-Hansen, I. and Matthews, A.M. and Avramovic, V. and Price, M. and Drogemoller, B. and Shyr, C. and Lee, J. and Mwenifumbo, J. and Ghani, A. and Stockler, S. and Friedman, J.M. and Lehman, A. and Ross, C.J. and Wasserman, W.W. and Tarailo-Graovac, M. and Horvath, G.A.
DOI: 10.1007/s10048-021-00652-7
2021Integrating disease and drug-related phenotypes for improved identification of pharmacogenomic variants
Pharmacogenomics
Ouellette, T.W. and Wright, G.E.B. and Drögemöller, B.I. and Ross, C.J.D. and Carleton, B.C.
DOI: 10.2217/pgs-2020-0130
2021Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity
npj Genomic Medicine
Scott, E.N. and Wright, G.E.B. and Drögemöller, B.I. and Hasbullah, J.S. and Gunaretnam, E.P. and Miao, F. and Bhavsar, A.P. and Shen, F. and Schneider, B.P. and Carleton, B.C. and Ross, C.J.D.
DOI: 10.1038/s41525-021-00199-4
2021RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy
Cell Stem Cell
Magdy, T. and Jiang, Z. and Jouni, M. and Fonoudi, H. and Lyra-Leite, D. and Jung, G. and Romero-Tejeda, M. and Kuo, H.-H. and Fetterman, K.A. and Gharib, M. and Burmeister, B.T. and Zhao, M. and Sapkota, Y. and Ross, C.J. and Carleton, B.C. and Bernstein, D. and Burridge, P.W.
DOI: 10.1016/j.stem.2021.08.006
2021Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study
The Lancet Child and Adolescent Health
Moke, D.J. and Luo, C. and Millstein, J. and Knight, K.R. and Rassekh, S.R. and Brooks, B. and Ross, C.J.D. and Wright, M. and Mena, V. and Rushing, T. and Esbenshade, A.J. and Carleton, B.C. and Orgel, E.
DOI: 10.1016/S2352-4642(21)00020-1
2021Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment
Biomedicine and Pharmacotherapy
Lin, J.J. and Loucks, C.M. and Trueman, J.N. and Drögemöller, B.I. and Wright, G.E.B. and Yoshida, E.M. and Ford, J.-A. and Lee, S.S. and Kim, R.B. and Al-Judaibi, B. and Schwarz, U.I. and Ramji, A. and Tam, E. and Ross, C.J. and Carleton, B.C.
DOI: 10.1016/j.biopha.2021.112195
2021Autoantibodies Against Lysosome Associated Membrane Protein-2 (LAMP-2) in Pediatric Chronic Primary Systemic Vasculitis
Frontiers in Immunology
Gibson, K.M. and Kain, R. and Luqmani, R.A. and Ross, C.J. and Cabral, D.A. and Brown, K.L.
DOI: 10.3389/fimmu.2020.624758
2021Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings
Annual Review of Pharmacology and Toxicology
Chang, W.-C. and Tanoshima, R. and Ross, C.J.D. and Carleton, B.C.
DOI: 10.1146/annurev-pharmtox-030920-025745
2021Neonatal T Helper 17 Responses Are Skewed Towards an Immunoregulatory Interleukin-22 Phenotype
Frontiers in Immunology
Razzaghian, H.R. and Sharafian, Z. and Sharma, A.A. and Boyce, G.K. and Lee, K. and Da Silva, R. and Orban, P.C. and Sekaly, R.-P. and Ross, C.J. and Lavoie, P.M.
DOI: 10.3389/fimmu.2021.655027
2021Different Disease Endotypes in Phenotypically Similar Vasculitides Affecting Small-to-Medium Sized Blood Vessels
Frontiers in Immunology
Gill, E.E. and Smith, M.L. and Gibson, K.M. and Morishita, K.A. and Lee, A.H.Y. and Falsafi, R. and Graham, J. and Foell, D. and Benseler, S.M. and Ross, C.J. and Luqmani, R.A. and Cabral, D.A. and Hancock, R.E.W. and Brown, K.L.
DOI: 10.3389/fimmu.2021.638571
2021Adult GAMT deficiency: A literature review and report of two siblings
Molecular Genetics and Metabolism Reports
Modi, B.P. and Khan, H.N. and van der Lee, R. and Wasim, M. and Haaxma, C.A. and Richmond, P.A. and Drögemöller, B. and Shah, S. and Salomons, G. and van der Kloet, F.M. and Vaz, F.M. and van der Crabben, S.N. and Ross, C.J. and Wasserman, W.W. and van Karnebeek, C.D.M. and Awan, F.R.
DOI: 10.1016/j.ymgmr.2021.100761
2021Economic Evidence on Potentially Curative Gene Therapy Products: A Systematic Literature Review
PharmacoEconomics
Ho, J.K. and Borle, K. and Dragojlovic, N. and Dhillon, M. and Kitchin, V. and Kopac, N. and Ross, C. and Lynd, L.D.
DOI: 10.1007/s40273-021-01051-4
2021Les tests pharmacogénomiques: Améliorer le recours personnalisé aux médicaments pour les patients
Canadian family physician Medecin de famille canadien
Loucks, C.M. and Groeneweg, G. and Roy, C. and Lee, D.K. and Rieder, M.J. and Lebel, D. and Ito, S. and Ross, C.J. and Carleton, B.C.
2020Pharmacogenomic testing: Enhancing personalized medication use for patients
Canadian Family Physician
Loucks, C.M. and Groeneweg, G. and Roy, C. and Lee, D.K. and Rieder, M.J. and Lebel, D. and Ito, S. and Ross, C.J. and Carleton, B.C.
2020CRISPR/Cas9 Editing: Sparking Discussion on Safety in Light of the Need for New Therapeutics
Human Gene Therapy
Carlaw, T.M. and Zhang, L.-H. and Ross, C.J.D.
DOI: 10.1089/hum.2020.111
2020Linkage analysis identifies an isolated strabismus locus at 14q12 overlapping with FOXG1 syndrome region
medRxiv
Ye, X. and Roslin, N.M. and Paterson, A.D. and Canada, C. and Lyons, C. and Pegado, V. and Richmond, P. and Shyr, C. and Fornes, O. and Han, X. and Higginson, M. and Ross, C.J. and Giaschi, D. and Gregory-Evans, C.Y. and Patel, M. and Wasserman, W.W.
DOI: 10.1101/2020.04.24.20077586
2020Epidemiologic Characteristics of Acute Kidney Injury during Cisplatin Infusions in Children Treated for Cancer
JAMA Network Open
McMahon, K.R. and Rassekh, S.R. and Schultz, K.R. and Blydt-Hansen, T. and Cuvelier, G.D.E. and Mammen, C. and Pinsk, M. and Carleton, B.C. and Tsuyuki, R.T. and Ross, C.J.D. and Palijan, A. and Huynh, L. and Yordanova, M. and Crépeau-Hubert, F. and Wang, S. and Boyko, D. and Zappitelli, M.
DOI: 10.1001/jamanetworkopen.2020.3639
2020A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency
Human Molecular Genetics
Al-Shekaili, H.H. and Petkau, T.L. and Pena, I. and Lengyell, T.C. and Verhoeven-Duif, N.M. and Ciapaite, J. and Bosma, M. and Van Faassen, M. and Kema, I.P. and Horvath, G. and Ross, C. and Simpson, E.M. and Friedman, J.M. and Van Karnebeek, C. and Leavitt, B.R.
DOI: 10.1093/hmg/ddaa202
2020Prevention of adverse drug effects: A pharmacogenomic approach
Current Opinion in Pediatrics
Scott, E.N. and Hasbullah, J.S. and Carleton, B.C. and Ross, C.J.D.
DOI: 10.1097/MOP.0000000000000935
2020A prospective study to explore the relationship between MTHFR C677T genotype, physiological folate levels, and postpartum psychopathology in at-risk women
PLoS ONE
Morris, E. and Hippman, C. and Albert, A. and Slomp, C. and Inglis, A. and Carrion, P. and Batallones, R. and Andrighetti, H. and Ross, C. and Dyer, R. and Honer, W. and Austin, J.
DOI: 10.1371/journal.pone.0243936
2020Pharmacokinetic-Pharmacogenomic Model for Chinese Children Treated With Lamotrigine Also Applies for Mexican Children
Therapeutic Drug Monitoring
Juárez-Hernández, J.E. and Gutiérrez-Ceniceros, M. and González-Ramírez, J.R. and Medeiros, M. and Carleton, B. and Ross, C. and Castañeda-Hernández, G.
DOI: 10.1097/FTD.0000000000000792
2020Vincristine-induced peripheral neurotoxicity: A prospective cohort.
Pediatric hematology and oncology
Nama N and Barker MK and Kwan C and Sabarre C and Solimano V and Rankin A and Raabe J and Ross CJ and Carleton B and Zwicker JG and Rassekh SR
DOI: 10.1080/08880018.2019.1677832
PubMed: 31682156
11/2019Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Arthritis & rheumatology (Hoboken, N.J.)
Gibson KM and Morishita KA and Dancey P and Moorehead P and Drögemöller B and Han X and Graham J and Hancock REW and Foell D and Benseler S and Luqmani R and Yeung RSM and Shenoi S and PedVas Investigators Network
DOI: 10.1002/art.40913
PubMed: 31008556
08/2019Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy.
American journal of human genetics
van Karnebeek CDM and Ramos RJ and Wen XY and Tarailo-Graovac M and Gleeson JG and Skrypnyk C and Brand-Arzamendi K and Karbassi F and Issa MY and van der Lee R and Wevers RA
DOI: 10.1016/j.ajhg.2019.07.015
PubMed: 31422819
08/2019An investigation of the glycosaminoglycan contribution to biaxial mechanical behaviours of porcine atrioventricular heart valve leaflets.
Journal of the Royal Society, Interface
Ross CJ and Laurence DW and Richardson J and Babu AR and Evans LE and Beyer EG and Childers RC and Wu Y and Towner RA and Fung KM and Mir A and Burkhart HM and Holzapfel GA and Lee CH
DOI: 10.1098/rsif.2019.0069
PubMed: 31266416
07/2019Genome-Wide Association Studies of Drug-Induced Liver Injury Make Progress Beyond the HLA Region.
Gastroenterology
Wright GEB and Drögemöller BI and Ross CJD and Carleton BC
DOI: 10.1053/j.gastro.2019.03.076
PubMed: 31348928
07/2019Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease
Wright GE and Caron NS and Ng B and Casal L and Xu X and Ooi J and Pouladi MA and Mostafavi S and Ross CJ and Hayden MR
DOI: 10.1101/699033
07/2019Pharmacogenomics of Cisplatin-Induced Ototoxicity: Successes, Shortcomings, and Future Avenues of Research.
Clinical pharmacology and therapeutics
Drögemöller BI and Wright GEB and Lo C and Le T and Brooks B and Bhavsar AP and Rassekh SR and Ross CJD and Carleton BC
DOI: 10.1002/cpt.1483
PubMed: 31012503
06/2019The influence of the noradrenergic/stress system on perceptual biases for reward.
Cognitive, affective & behavioral neuroscience
Ehlers MR and Ross CJD and Todd RM
DOI: 10.3758/s13415-018-00657-0
PubMed: 30357659
06/2019Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.
American journal of human genetics
Wright GEB and Collins JA and Kay C and McDonald C and Dolzhenko E and Xia Q and Becanovic K and Drögemöller BI and Semaka A and Nguyen CM and Trost B and Richards F and Bijlsma EK and Hayden MR
DOI: 10.1016/j.ajhg.2019.04.007
PubMed: 31104771
05/2019Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients.
Genes
Zazuli Z and Otten LS and Drögemöller BI and Medeiros M and Monzon JG and Wright GEB and Kollmannsberger CK and Bedard PL and Chen Z and Gelmon KA and McGoldrick N and Kitchlu A and Maitland-van der Zee AH
DOI: 10.3390/genes10050364
PubMed: 31083486
05/2019Common variants of the oxytocin receptor gene do not predict the positive mood benefits of prosocial spending.
Emotion (Washington, D.C.)
Whillans AV and Aknin LB and Ross CJ and Chen L and Chen FS
DOI: 10.1037/emo0000589
PubMed: 31021112
04/2019Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.
Cardiovascular research
Chow EJ and Leger KJ and Bhatt NS and Mulrooney DA and Ross CJ and Aggarwal S and Bansal N and Ehrhardt MJ and Armenian SH and Scott JM and Hong B
DOI: 10.1093/cvr/cvz031
PubMed: 30768157
04/2019Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS.
The New England Journal of Medicine
van Kuilenburg ABP and Tarailo-Graovac M and Richmond PA and Drögemöller BI and Pouladi MA and Leen R and Brand-Arzamendi K and Dobritzsch D and Dolzhenko E and Eberle MA and van Karnebeek CDM
DOI: 10.1056/nejmoa1806627
PubMed: 30970188
04/2019PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights.
Brain : a journal of neurology
Johnstone DL and Al-Shekaili HH and Tarailo-Graovac M and Wolf NI and Ivy AS and Demarest S and Roussel Y and Ciapaite J and van Roermund CWT and Kernohan KD and Kosuta C and Ban K and van Karnebeek CDM
DOI: 10.1093/brain/awy346
PubMed: 30668673
03/2019Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure.
Biochimica et biophysica acta. Molecular basis of disease
Pérez-Torras S and Mata-Ventosa A and Drögemöller B and Tarailo-Graovac M and Meijer J and Meinsma R and van Cruchten AG and Kulik W and Viel-Oliva A and Bidon-Chanal A and van Kuilenburg ABP
DOI: 10.1016/j.bbadis.2019.01.013
PubMed: 30658162
01/2019Morphine biotransformation genes and neonatal clinical factors predicted behaviour problems in very preterm children at 18¿months.
EBioMedicine
Chau CMY and Ross CJD and Chau V and Synnes AR and Miller SP and Carleton B and Grunau RE
DOI: 10.1016/j.ebiom.2019.01.042
PubMed: 30709768
01/2019Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function.
JCI insight
Wen XY and Tarailo-Graovac M and Brand-Arzamendi K and Willems A and Rakic B and Huijben K and Da Silva A and Pan X and El-Rass S and Ng R and Selby K and Philip AM and Yun J and Ye XC and Lefeber DJ
DOI: 10.1172/jci.insight.122373
PubMed: 30568043
12/2018Atypical cerebral palsy: genomics analysis enables precision medicine.
Genetics in medicine : official journal of the American College of Medical Genetics
Matthews AM and Blydt-Hansen I and Al-Jabri B and Andersen J and Tarailo-Graovac M and Price M and Selby K and Demos M and Connolly M and Drögemoller B and Shyr C and Mwenifumbo J and United for Metabolic Diseases and the CAUSES Study
DOI: 10.1038/s41436-018-0376-y
PubMed: 30542205
12/2018HUME: large-scale detection of causal genetic factors of adverse drug reactions.
Bioinformatics (Oxford, England)
Mansouri M and Yuan B and Ross CJD and Carleton BC and Ester M
DOI: 10.1093/bioinformatics/bty475
PubMed: 29931042
12/2018CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines.
Breast cancer research and treatment
Drögemöller BI and Wright GEB and Shih J and Monzon JG and Gelmon KA and Ross CJD and Amstutz U and Carleton BC and CPNDS Clinical Recommendations Group
DOI: 10.1007/s10549-018-5027-0
PubMed: 30411242
11/2018Cellular metabolism constrains innate immune responses in early human ontogeny.
Nature communications
Kan B and Michalski C and Fu H and Au HHT and Lee K and Marchant EA and Cheng MF and Anderson-Baucum E and Aharoni-Simon M and Tilley P and Mirmira RG and Ross CJ and Luciani DS and Jan E and Lavoie PM
DOI: 10.1038/s41467-018-07215-9
PubMed: 30446641
11/2018Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database.
Journal of clinical pharmacology
Tanoshima R and Khan A and Biala AK and Trueman JN and Drögemöller BI and Wright GEB and Hasbullah JS and Groeneweg GSS and Ross CJD and Carleton BC and Canadian Pharmacogenomics Network for Drug Safety Consortium
DOI: 10.1002/jcph.1336
PubMed: 30452777
11/2018S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies.
Frontiers in pediatrics
Brown KL and Lubieniecka JM and Armaroli G and Kessel K and Gibson KM and Graham J and Liu D and Hancock REW and Ross CJ and Benseler SM and Luqmani RA and Cabral DA and Foell D and Kessel C
DOI: 10.3389/fped.2018.00341
PubMed: 30533405
11/2018Affectively biased competition: sustained attention is tuned to rewarding expressions and is not modulated by norepinephrine receptor gene variant
Roberts KH and Manaligod MGM and Ross CJD and Müller DJ and Wieser MJ and Todd RM
DOI: 10.1101/442863
10/2018Reducing anthracycline-induced cardiotoxicity through pharmacogenetics.
Pharmacogenomics
Scott E and Hasbullah JS and Ross CJ and Carleton BC
DOI: 10.2217/pgs-2018-0124
PubMed: 30213233
09/2018Output from the CIHR Canadian HIV Trials Network international postdoctoral fellowship for capacity building in HIV clinical trials.
HIV/AIDS (Auckland, N.Z.)
Mbuagbaw L and Slogrove AL and Sas J and Lengwe Kunda J and Morfaw F and Mukonzo JK and Cao W and Ngomba-Kadima G and Zunza M and Ongolo-Zogo P and Nana PN and Cockcroft A and Anis AH
DOI: 10.2147/HIV.S150107
PubMed: 30147378
08/2018Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.
Clinical pharmacology and therapeutics
Wright GEB and Amstutz U and Drögemöller BI and Shih J and Rassekh SR and Hayden MR and Carleton BC and Ross CJD and Canadian Pharmacogenomics Network for Drug Safety Consortium
DOI: 10.1002/cpt.1179
PubMed: 29999516
08/2018A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents.
Child and Adolescent Psychiatry and Mental Health
Dodsworth T and Kim DD and Procyshyn RM and Ross CJ and Honer WG and Barr AM
DOI: 10.1186/s13034-018-0243-2
PubMed: 30026806
07/2018Common variation near IRF6 is associated with IFN-ß-induced liver injury in multiple sclerosis.
Nature genetics
Kowalec K and Wright GEB and Drögemöller BI and Aminkeng F and Bhavsar AP and Kingwell E and Yoshida EM and Traboulsee A and Marrie RA and Kremenchutzky M and Campbell TL and Carleton BC
DOI: 10.1038/s41588-018-0168-y
PubMed: 30013178
07/2018Gain-of-function KCNJ6 Mutation in a Severe Hyperkinetic Movement Disorder Phenotype.
Neuroscience
Horvath GA and Zhao Y and Tarailo-Graovac M and Boelman C and Gill H and Shyr C and Lee J and Blydt-Hansen I and Drögemöller BI and Moreland J and Ross CJ and Wasserman WW and van Karnebeek CDM
DOI: 10.1016/j.neuroscience.2018.05.031
PubMed: 29852244
05/2018Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G > A and a large intragenic inversion in DPYD spanning intron 8 to intron 12.
Human mutation
van Kuilenburg ABP and Tarailo-Graovac M and Meijer J and Drogemoller B and Vockley J and Maurer D and Dobritzsch D and Ross CJ and Wasserman W and Meinsma R and Zoetekouw L and van Karnebeek CDM
DOI: 10.1002/humu.23538
PubMed: 29691939
04/2018Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients.
Clinical cancer research : an official journal of the American Association for Cancer Research
Drögemöller BI and Brooks B and Critchley C and Monzon JG and Wright GEB and Liu G and Renouf DJ and Kollmannsberger CK and Bedard PL and Hayden MR and Gelmon KA and Carleton BC and Ross CJD
DOI: 10.1158/1078-0432.ccr-17-2810
PubMed: 29358504
04/2018Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral Palsy.
PM & R : the journal of injury, function, and rehabilitation
McLaughlin MJ and He Y and Brunstrom-Hernandez J and Thio LL and Carleton BC and Ross CJD and Gaedigk A and Lewandowski A and Dai H and Jusko WJ and Leeder JS
DOI: 10.1016/j.pmrj.2017.08.441
PubMed: 28867665
03/2018Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.
Neurology
McCormack M and Gui H and Ingason A and Speed D and Wright GEB and Zhang EJ and Secolin R and Yasuda C and Kwok M and Wolking S and Becker F and Rau S and Avbersek A and Heggeli K and Leu C and Cavalleri GL
DOI: 10.1212/wnl.0000000000004853
PubMed: 29288229
01/2018The genotypic and phenotypic spectrum of MTO1 deficiency.
Molecular genetics and metabolism
O'Byrne JJ and Tarailo-Graovac M and Ghani A and Champion M and Deshpande C and Dursun A and Ozgul RK and Freisinger P and Garber I and Haack TB and Horvath R and Baric I and Husain RA and van Karnebeek CDM
DOI: 10.1016/j.ymgme.2017.11.003
PubMed: 29331171
01/2018Improvement of Self-Injury With Dopamine and Serotonin Replacement Therapy in a Patient With a Hemizygous PAK3 Mutation: A New Therapeutic Strategy for Neuropsychiatric Features of an Intellectual Disability Syndrome.
Journal of child neurology
Horvath GA and Tarailo-Graovac M and Bartel T and Race S and Van Allen MI and Blydt-Hansen I and Ross CJ and Wasserman WW and Connolly MB and van Karnebeek CDM
DOI: 10.1177/0883073817740443
PubMed: 29246092
01/2018An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines.
Pediatric blood & cancer
Dionne F and Aminkeng F and Bhavsar AP and Groeneweg G and Smith A and Visscher H and Rassekh SR and Ross C and Carleton B
DOI: 10.1002/pbc.26887
PubMed: 29271558
12/2017Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.
JAMA oncology
Drögemöller BI and Monzon JG and Bhavsar AP and Borrie AE and Brooks B and Wright GEB and Liu G and Renouf DJ and Kollmannsberger CK and Bedard PL and Aminkeng F and Amstutz U and Carleton BC
DOI: 10.1001/jamaoncol.2017.0502
PubMed: 28448657
11/2017A de novo mosaic mutation in SPAST with two novel alternative alleles and chromosomal copy number variant in a boy with spastic paraplegia and autism spectrum disorder.
European journal of medical genetics
Matthews AM and Tarailo-Graovac M and Price EM and Blydt-Hansen I and Ghani A and Drögemöller BI and Robinson WP and Ross CJ and Wasserman WW and Siden H and van Karnebeek CD
DOI: 10.1016/j.ejmg.2017.07.015
PubMed: 28778789
10/2017Exploring genetic influences underlying acute aerobic exercise effects on motor learning.
Scientific reports
Mang CS and McEwen LM and MacIsaac JL and Snow NJ and Campbell KL and Kobor MS and Ross CJD and Boyd LA
DOI: 10.1038/s41598-017-12422-3
PubMed: 28935933
09/2017Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia.
BMJ open
Kowalec K and Kingwell E and Carruthers R and Marrie RA and Bernatsky S and Traboulsee A and Ross CJD and Carleton B and Tremlett H
DOI: 10.1136/bmjopen-2017-016276
PubMed: 28576902
06/2017A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis.
Genome medicine
Ross CJ and Towfic F and Shankar J and Laifenfeld D and Thoma M and Davis M and Weiner B and Kusko R and Zeskind B and Knappertz V and Grossman I and Hayden MR
DOI: 10.1186/s13073-017-0436-y
PubMed: 28569182
05/2017Corrigendum: NANS-mediated synthesis of sialic acid is required for brain and skeletal development.
Nature genetics
van Karnebeek CDM and Bonafé L and Wen XY and Tarailo-Graovac M and Balzano S and Royer-Bertrand B and Ashikov A and Garavelli L and Mammi I and Turolla L and Breen C and Donnai D and Superti-Furga A
DOI: 10.1038/ng0617-969a
PubMed: 28546570
05/2017A case of splenomegaly in CBL syndrome.
Coe RR and McKinnon ML and Tarailo-Graovac M and Ross CJ and Wasserman WW and Friedman JM and Rogers PC and van Karnebeek CDM
DOI: 10.1016/j.ejmg.2017.04.009
PubMed: 28414188
04/2017Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer.
Aminkeng F and Ross CJ and Rassekh SR and Rieder MJ and Bhavsar AP and Sanatani S and Bernstein D and Hayden MR and Amstutz U and Carleton BC
DOI: 10.1111/bcp.13218
PubMed: 28317142
03/2017A girl with developmental delay, ataxia, cranial nerve palsies, severe respiratory problems in infancy-Expanding NDST1 syndrome.
Armstrong L and Tarailo-Graovac M and Sinclair G and Seath KI and Wasserman WW and Ross CJ and van Karnebeek CD
DOI: 10.1002/ajmg.a.37621
PubMed: 28211985
03/2017The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.
Kay C and Tirado-Hurtado I and Cornejo-Olivas M and Collins JA and Wright G and Inca-Martinez M and Veliz-Otani D and Ketelaar ME and Slama RA and Ross CJ and Mazzetti P and Hayden MR
DOI: 10.1038/ejhg.2016.169
PubMed: 28000697
02/2017Identification of a large intronic transposal insertion in SLC17A5 causing sialic acid storage disease.
Tarailo-Graovac M and Drögemöller BI and Wasserman WW and Ross CJ and van den Ouweland AM and Darin N and Kollberg G and van Karnebeek CD and Blomqvist M
DOI: 10.1186/s13023-017-0584-6
PubMed: 28187749
02/2017Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.
McMahon KR and Rod Rassekh S and Schultz KR and Pinsk M and Blydt-Hansen T and Mammen C and Tsuyuki RT and Devarajan P and Cuvelier GD and Mitchell LG and Baruchel S and Palijan A and Carleton BC and Ross CJ and Zappitelli M and Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Group
DOI: 10.1177/2054358117690338
PubMed: 28270931
2017Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines.
Bhavsar AP and Gunaretnam EP and Li Y and Hasbullah JS and Carleton BC and Ross CJ
DOI: 10.1371/journal.pone.0175711
PubMed: 28406961
2017Mitochondrial Complex III Deficiency with Ketoacidosis and Hyperglycemia Mimicking Neonatal Diabetes.
Anastasio N and Tarailo-Graovac M and Al-Khalifah R and Legault L and Drogemoller B and Ross CJ and Wasserman WW and van Karnebeek C and Buhas D
DOI: 10.1007/8904_2016_557
PubMed: 27074787
2017Editorial Note to:Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Wang Z and Sadovnick AD and Traboulsee AL and Ross JP and Bernales CQ and Encarnacion M and Yee IM and de Lemos M and Greenwood T and Lee JD and Wright G and Ross CJ and Zhang S and Song W and Vilariño-Güell C
DOI: 10.1016/j.neuron.2016.10.008
PubMed: 27764666
10/2016The global spectrum of protein-coding pharmacogenomic diversity.
Wright GE and Carleton B and Hayden MR and Ross CJ
DOI: 10.1038/tpj.2016.77
PubMed: 27779249
10/2016Case-Control Studies Are Not Familial Studies.
Wang Z and Sadovnick AD and Traboulsee AL and Ross JP and Bernales CQ and Encarnacion M and Yee IM and de Lemos M and Greenwood T and Lee JD and Wright G and Ross CJ and Zhang S and Song W and Vilariño-Güell C
DOI: 10.1016/j.neuron.2016.09.053
PubMed: 27764669
10/2016Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.
Aminkeng F and Ross CJ and Rassekh SR and Hwang S and Rieder MJ and Bhavsar AP and Smith A and Sanatani S and Gelmon KA and Bernstein D and Hayden MR and Amstutz U and Carleton BC and CPNDS Clinical Practice Recommendations Group
DOI: 10.1111/bcp.13008
PubMed: 27197003
09/2016A Tetra-Primer Amplification Refractory System Technique for the Cost-Effective and Novel Genotyping of Eight Single-Nucleotide Polymorphisms of the Catechol-O-Methyltransferase Gene.
Wang CK and Aleksic A and Xu MS and Procyshyn RM and Ross CJ and Vila-Rodriguez F and Ramos-Miguel A and Yan R and Honer WG and Barr AM
DOI: 10.1089/gtmb.2015.0304
PubMed: 27228319
08/2016Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers.
Lee JW and Pussegoda K and Rassekh SR and Monzon JG and Liu G and Hwang S and Bhavsar AP and Pritchard S and Ross CJ and Amstutz U and Carleton BC and CPNDS Clinical Recommendations Group
DOI: 10.1097/ftd.0000000000000298
PubMed: 26960170
08/2016NANS-mediated synthesis of sialic acid is required for brain and skeletal development.
van Karnebeek CD and Bonafé L and Wen XY and Tarailo-Graovac M and Balzano S and Royer-Bertrand B and Ashikov A and Garavelli L and Mammi I and Turolla L and Breen C and Donnai D and Cormier V and Heron D and Nishimura G and Uchikawa S and Campos-Xavier B and Rossi A and Hennet T and Brand-Arzamendi K
DOI: 10.1038/ng.3578
PubMed: 27213289
07/2016Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Wang Z and Sadovnick AD and Traboulsee AL and Ross JP and Bernales CQ and Encarnacion M and Yee IM and de Lemos M and Greenwood T and Lee JD and Wright G and Ross CJ and Zhang S and Song W and Vilariño-Güell C
DOI: 10.1016/j.neuron.2016.04.039
PubMed: 27253448
06/2016Exome Sequencing and the Management of Neurometabolic Disorders.
Tarailo-Graovac M and Shyr C and Ross CJ and Horvath GA and Salvarinova R and Ye XC and Zhang LH and Bhavsar AP and Lee JJ and Drögemöller BI and Abdelsayed M and Alfadhel M and Armstrong L and Baumgartner MR and Burda P and Connolly MB and Cameron J and Demos M and Dewan T and Dionne J
DOI: 10.1056/nejmoa1515792
PubMed: 27276562
06/2016De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome.
Langlois S and Tarailo-Graovac M and Sayson B and Drögemöller B and Swenerton A and Ross CJ and Wasserman WW and van Karnebeek CD
DOI: 10.1038/ejhg.2015.217
PubMed: 26486474
06/2016Cytosolic phosphoenolpyruvate carboxykinase deficiency presenting with acute liver failure following gastroenteritis.
Santra S and Cameron JM and Shyr C and Zhang L and Drögemöller B and Ross CJ and Wasserman WW and Wevers RA and Rodenburg RJ and Gupte G and Preece MA and van Karnebeek CD
DOI: 10.1016/j.ymgme.2016.03.001
PubMed: 26971250
05/2016Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research.
Progress in neurobiology
Grossman I and Knappertz V and Laifenfeld D and Ross C and Zeskind B and Kolitz S and Ladkani D and Hayardeny L and Loupe P and Laufer R and Hayden M
DOI: 10.1016/j.pneurobio.2016.02.001
PubMed: 26952809
03/2016Forensic Investigation of Methadone Concentrations in Deceased Breastfed Infants.
Madadi P and Kelly LE and Ross CJ and Kepron C and Edwards JN and Koren G
DOI: 10.1111/1556-4029.12972
PubMed: 26513313
03/2016Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.
Cohen AS and Yap DB and Lewis ME and Chijiwa C and Ramos-Arroyo MA and Tkachenko N and Milano V and Fradin M and McKinnon ML and Townsend KN and Xu J and Van Allen MI and Ross CJ and Dobyns WB and Weaver DD and Gibson WT
DOI: 10.1002/humu.22946
PubMed: 26694085
03/2016Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
Horvath GA and Demos M and Shyr C and Matthews A and Zhang L and Race S and Stockler-Ipsiroglu S and Van Allen MI and Mancarci O and Toker L and Pavlidis P and Ross CJ and Wasserman WW and Trump N and Heales S and Pope S and Cross JH and van Karnebeek CD
DOI: 10.1016/j.ymgme.2015.11.008
PubMed: 26647175
01/2016Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics.
Chan SL and Samaranayake N and Ross CJ and Toh MT and Carleton B and Hayden MR and Teo YY and Dissanayake VH and Brunham LR
DOI: 10.1097/fpc.0000000000000182
PubMed: 26444257
01/2016Further Validation of the SIGMAR1 c.151+1G>T Mutation as Cause of Distal Hereditary Motor Neuropathy.
Child neurology open
Lee JJY and van Karnebeek CDM and Drögemoller B and Shyr C and Tarailo-Graovac M and Eydoux P and Ross CJ and Wasserman WW and Björnson B and Wu JK
DOI: 10.1177/2329048x16669912
PubMed: 28503617
2016Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry.
Kay C and Collins JA and Skotte NH and Southwell AL and Warby SC and Caron NS and Doty CN and Nguyen B and Griguoli A and Ross CJ and Squitieri F and Hayden MR
DOI: 10.1038/mt.2015.128
PubMed: 26201449
11/2015The pharmacogenetics of codeine pain relief in the postpartum period.
Baber M and Chaudhry S and Kelly L and Ross C and Carleton B and Berger H and Koren G
DOI: 10.1038/tpj.2015.3
PubMed: 25752520
10/2015RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multiorgan involvement.
Janer A and van Karnebeek CD and Sasarman F and Antonicka H and Al Ghamdi M and Shyr C and Dunbar M and Stockler-Ispiroglu S and Ross CJ and Vallance H and Dionne J and Wasserman WW and Shoubridge EA
DOI: 10.1038/ejhg.2014.293
PubMed: 25604853
10/2015A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.
Aminkeng F and Bhavsar AP and Visscher H and Rassekh SR and Li Y and Lee JW and Brunham LR and Caron HN and van Dalen EC and Kremer LC and van der Pal HJ and Amstutz U and Rieder MJ and Bernstein D and Carleton BC and Hayden MR and Ross CJ and Canadian Pharmacogenomics Network for Drug Safety Consortium
DOI: 10.1038/ng.3374
PubMed: 26237429
09/2015Development of a cost-efficient novel method for rapid, concurrent genotyping of five common single nucleotide polymorphisms of the brain derived neurotrophic factor (BDNF) gene by tetra-primer amplification refractory mutation system.
Wang CK and Xu MS and Ross CJ and Lo R and Procyshyn RM and Vila-Rodriguez F and White RF and Honer WG and Barr AM
DOI: 10.1002/mpr.1475
PubMed: 26118823
09/2015Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort Study.
Jiménez-Triana CA and Castelán-Martínez OD and Rivas-Ruiz R and Jiménez-Méndez R and Medina A and Clark P and Rassekh R and Castañeda-Hernández G and Carleton B and Medeiros M and Canadian Pharmacogenomics Network for Drug Safety Consortium
DOI: 10.1097/md.0000000000001413
PubMed: 26313789
08/2015Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy.
Shaw K and Amstutz U and Kim RB and Lesko LJ and Turgeon J and Michaud V and Hwang S and Ito S and Ross C and Carleton BC and CPNDS Clinical Recommendation Group
DOI: 10.1097/ftd.0000000000000192
PubMed: 26186657
08/2015Genetic determinants of cocaine-associated agranulocytosis.
Buxton JA and Omura J and Kuo M and Ross C and Tzemis D and Purssell R and Gardy J and Carleton B
DOI: 10.1186/s13104-015-1219-4
PubMed: 26070312
06/2015Association between regulatory advisories and codeine prescribing to postpartum women.
Smolina K and Weymann D and Morgan S and Ross C and Carleton B
DOI: 10.1001/jama.2015.3642
PubMed: 25965237
05/2015Expansion of the QARS deficiency phenotype with report of a family with isolated supratentorial brain abnormalities.
Salvarinova R and Ye CX and Rossi A and Biancheri R and Roland EH and Pavlidis P and Ross CJ and Tarailo-Graovac M and Wasserman WW and van Karnebeek CD
DOI: 10.1007/s10048-014-0432-y
PubMed: 25432320
04/2015Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms.
Sirrs S and van Karnebeek CD and Peng X and Shyr C and Tarailo-Graovac M and Mandal R and Testa D and Dubin D and Carbonetti G and Glynn SE and Sayson B and Robinson WP and Han B and Wishart D and Ross CJ and Wasserman WW and Hurwitz TA and Sinclair G and Kaczocha M
DOI: 10.1186/s13023-015-0248-3
PubMed: 25885783
03/2015Use of pharmacogenomics in pediatric renal transplant recipients.
Medeiros M and Castañeda-Hernández G and Ross CJ and Carleton BC
DOI: 10.3389/fgene.2015.00041
PubMed: 25741362
2015Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children.
Visscher H and Rassekh SR and Sandor GS and Caron HN and van Dalen EC and Kremer LC and van der Pal HJ and Rogers PC and Rieder MJ and Carleton BC and Hayden MR and Ross CJ and CPNDS consortium
DOI: 10.2217/pgs.15.61
PubMed: 26230641
2015The genotypic and phenotypic spectrum of PIGA deficiency.
Tarailo-Graovac M and Sinclair G and Stockler-Ipsiroglu S and Van Allen M and Rozmus J and Shyr C and Biancheri R and Oh T and Sayson B and Lafek M and Ross CJ and Robinson WP and Wasserman WW and Rossi A and van Karnebeek CD
DOI: 10.1186/s13023-015-0243-8
PubMed: 25885527
2015A single bout of high-intensity aerobic exercise facilitates response to paired associative stimulation and promotes sequence-specific implicit motor learning.
Mang CS and Snow NJ and Campbell KL and Ross CJ and Boyd LA
DOI: 10.1152/japplphysiol.00498.2014
PubMed: 25257866
12/2014Pharmacogenomic diversity in Singaporean populations and Europeans.
Brunham LR and Chan SL and Li R and Aminkeng F and Liu X and Saw WY and Ong RT and Pillai EN and Carleton BC and Toh D and Tan SH and Koo SH and Lee EJ and Chia KS and Ross CJ and Hayden MR and Sung C and Teo YY
DOI: 10.1038/tpj.2014.22
PubMed: 24861855
12/2014Hearing loss in Mexican children treated with cisplatin.
Castelán-Martínez OD and Jiménez-Méndez R and Rodríguez-Islas F and Fierro-Evans M and Vázquez-Gómez BE and Medina-Sansón A and Clark P and Carleton B and Ross C and Hildebrand C and Castañeda-Hernández G and Rivas-Ruiz R
DOI: 10.1016/j.ijporl.2014.06.007
PubMed: 25037447
09/2014Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic trafficking.
Stockler S and Corvera S and Lambright D and Fogarty K and Nosova E and Leonard D and Steinfeld R and Ackerley C and Shyr C and Au N and Selby K and van Allen M and Vallance H and Wevers R and Watkins D and Rosenblatt D and Ross CJ and Conibear E and Wasserman W and van Karnebeek C
DOI: 10.1186/s13023-014-0141-5
PubMed: 25233840
09/2014Genetic markers of cisplatin-induced hearing loss in children.
Carleton BC and Ross CJ and Pussegoda K and Bhavsar AP and Visscher H and Lee JW and Brooks B and Rassekh SR and Dubé MP and Hayden MR
DOI: 10.1038/clpt.2014.92
PubMed: 25141953
09/2014Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity".
Carleton BC and Ross CJ and Bhavsar AP and Lee JW and Visscher H and Rassekh SR and Hayden MR
DOI: 10.1038/clpt.2014.90
PubMed: 24755913
08/2014AIMP1 deficiency presents as a cortical neurodegenerative disease with infantile onset.
Armstrong L and Biancheri R and Shyr C and Rossi A and Sinclair G and Ross CJ and Tarailo-Graovac M and Wasserman WW and van Karnebeek CD
DOI: 10.1007/s10048-014-0411-3
PubMed: 24958424
08/2014The emerging era of pharmacogenomics: current successes, future potential, and challenges.
Lee JW and Aminkeng F and Bhavsar AP and Shaw K and Carleton BC and Hayden MR and Ross CJ
DOI: 10.1111/cge.12392
PubMed: 24684508
07/2014VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
Shaw K and Amstutz U and Hildebrand C and Rassekh SR and Hosking M and Neville K and Leeder JS and Hayden MR and Ross CJ and Carleton BC
DOI: 10.1002/pbc.24932
PubMed: 24474498
06/2014Codeine-related deaths: The role of pharmacogenetics and drug interactions.
Lam J and Woodall KL and Solbeck P and Ross CJ and Carleton BC and Hayden MR and Koren G and Madadi P
DOI: 10.1016/j.forsciint.2014.03.018
PubMed: 24747667
06/2014Development of a broad-based ADME panel for use in pharmacogenomic studies.
Brown AM and Renaud Y and Ross C and Hansen M and Mongrain I and Valois D and Carleton BC and Hayden MR and Dubé MP and Tardif JC and Phillips MS
DOI: 10.2217/pgs.14.81
PubMed: 25141894
06/2014Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.
Aminkeng F and Ross CJ and Rassekh SR and Brunham LR and Sistonen J and Dube MP and Ibrahim M and Nyambo TB and Omar SA and Froment A and Bodo JM and Tishkoff S and Carleton BC and Hayden MR and Canadian Pharmacogenomics Network for Drug Safety Consortium
DOI: 10.1038/tpj.2013.13
PubMed: 23588107
04/2014DNAJC13 mutations in Parkinson disease.
Vilariño-Güell C and Rajput A and Milnerwood AJ and Shah B and Szu-Tu C and Trinh J and Yu I and Encarnacion M and Munsie LN and Tapia L and Gustavsson EK and Chou P and Tatarnikov I and Evans DM and Pishotta FT and Volta M and Beccano-Kelly D and Thompson C and Lin MK and Sherman HE
DOI: 10.1093/hmg/ddt570
PubMed: 24218364
04/2014Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity.
Carleton BC and Ross CJ and Bhavsar AP and Amstutz U and Pussegoda K and Visscher H and Lee JW and Brooks B and Rassekh SR and Dubé MP and Hayden MR
DOI: 10.1038/clpt.2013.219
PubMed: 24193170
03/2014Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood.
van Karnebeek CD and Sly WS and Ross CJ and Salvarinova R and Yaplito-Lee J and Santra S and Shyr C and Horvath GA and Eydoux P and Lehman AM and Bernard V and Newlove T and Ukpeh H and Chakrapani A and Preece MA and Ball S and Pitt J and Vallance HD and Coulter-Mackie M and Nguyen H
DOI: 10.1016/j.ajhg.2014.01.006
PubMed: 24530203
03/2014Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.
PloS one
Mukonzo JK and Owen JS and Ogwal-Okeng J and Kuteesa RB and Nanzigu S and Sewankambo N and Thabane L and Gustafsson LL and Ross C and Aklillu E
DOI: 10.1371/journal.pone.0086919
PubMed: 24497997
01/2014A novel recurrent mutation in ATP1A3 causes CAPOS syndrome.
Demos MK and van Karnebeek CD and Ross CJ and Adam S and Shen Y and Zhan SH and Shyr C and Horvath G and Suri M and Fryer A and Jones SJ and Friedman JM and FORGE Canada Consortium
DOI: 10.1186/1750-1172-9-15
PubMed: 24468074
01/2014Exome sequencing pilot study in children with carbamazepine-induced serious skin reactions.
Amstutz U and Shyr C and Shear NH and Rieder MJ and Wasserman WW and Ross CJ and Carleton BC
DOI: 10.1186/2045-7022-4-s3-p119
2014Genetic markers of cisplatin-induced hearing loss in children
Clinical Advances in Hematology and Oncology
Carleton, B.C. and Ross, C.J. and Hayden, M.R.
2014Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor.
Mang CS and Campbell KL and Ross CJ and Boyd LA
DOI: 10.2522/ptj.20130053
PubMed: 23907078
12/2013Instructor comfort level in high-fidelity simulation.
Harder BN and Ross CJ and Paul P
DOI: 10.1016/j.nedt.2012.09.003
PubMed: 23025906
10/2013Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.
Pussegoda K and Ross CJ and Visscher H and Yazdanpanah M and Brooks B and Rassekh SR and Zada YF and Dubé MP and Carleton BC and Hayden MR and CPNDS Consortium
DOI: 10.1038/clpt.2013.80
PubMed: 23588304
08/2013Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children.
Visscher H and Ross CJ and Rassekh SR and Sandor GS and Caron HN and van Dalen EC and Kremer LC and van der Pal HJ and Rogers PC and Rieder MJ and Carleton BC and Hayden MR and CPNDS Consortium
DOI: 10.1002/pbc.24505
PubMed: 23441093
08/2013Putative association of ABCB1 2677G>T/A with oxycodone-induced central nervous system depression in breastfeeding mothers.
Lam J and Kelly L and Matok I and Ross CJ and Carleton BC and Hayden MR and Madadi P and Koren G
DOI: 10.1097/ftd.0b013e318288f158
PubMed: 23783165
08/2013HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.
Amstutz U and Ross CJ and Castro-Pastrana LI and Rieder MJ and Shear NH and Hayden MR and Carleton BC and CPNDS Consortium
DOI: 10.1038/clpt.2013.55
PubMed: 23588310
07/2013From mutation identification to therapy: discovery and origins of the first approved gene therapy in the Western world.
Kastelein JJ and Ross CJ and Hayden MR
DOI: 10.1089/hum.2013.063
PubMed: 23578007
05/2013Cancer pharmacogenomics in children: research initiatives and progress to date.
Rassekh SR and Ross CJ and Carleton BC and Hayden MR
DOI: 10.1007/s40272-013-0021-9
PubMed: 23529868
04/2013Cancer Pharmacogenomics in Children
Cancer Genomics: From Bench to Personalized Medicine
Rassekh, S.R. and Ross, C.J.D.
DOI: 10.1016/B978-0-12-396967-5.00006-2
2013The Salmonella type III effector SspH2 specifically exploits the NLR co-chaperone activity of SGT1 to subvert immunity.
Bhavsar AP and Brown NF and Stoepel J and Wiermer M and Martin DD and Hsu KJ and Imami K and Ross CJ and Hayden MR and Foster LJ and Li X and Hieter P and Finlay BB
DOI: 10.1371/journal.ppat.1003518
PubMed: 23935490
2013A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk.
Kelly LE and Chaudhry SA and Rieder MJ and 't Jong G and Moretti ME and Lausman A and Ross C and Berger H and Carleton B and Hayden MR and Madadi P and Koren G
DOI: 10.1371/journal.pone.0070073
PubMed: 23922910
2013Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy
Journal of Population Therapeutics and Clinical Pharmacology
Madadi, P. and Amstutz, U. and Rieder, M. and Ito, S. and Fung, V. and Hwang, S. and Turgeon, J. and Michaud, V. and Koren, G. and Carleton, B.C. and Hayden, M.R. and Ross, C.J. and MacLeod, S. and Rassekh, R. and Lauder, G. and Smith, A. and Brunham, L. and Shear, N.H. and Liu, G. and Kim, R. and Maher, M. and Flockhart, D.
2013Erratum: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy (Nature Genetics (2009) 41 (1345-1349))
Nature Genetics
Ross, C.J.D. and Katzov-Eckert, H. and Dubé, M.-P. and Brooks, B. and Rassekh, S.R. and Barhdadi, A. and Feroz-Zada, Y. and Visscher, H. and Brown, A.M.K. and Rieder, M.J. and Rogers, P.C. and Phillips, M.S. and Carleton, B.C. and Hayden, M.R.
DOI: 10.1038/ng.0513-578
2013Pharmacogenomic investigation of adverse drug reactions(ADRs): the ADR prioritization tool, APT.
Shaw K and Amstutz U and Castro-Pastrana L and Loo TT and Ross CJ and Ito S and Reider MJ and Maher M and Macleod S and Koren G and Hayden MR and Carleton BC
PubMed: 23824325
2013Pharmacogenomic investigation of adverse drug reactions (ADRS): The ADR prioritization tool, APT
Journal of Population Therapeutics and Clinical Pharmacology
Shaw, K. and Amstutz, U. and Castro-Pastrana, L. and Loo, T.T. and Ross, C.J. and Ito, S. and Rieder, M.J. and Maher, M. and MacLeod, S. and Koren, G. and Hayden, M.R. and Carleton, B.C.
2013Life-threatening adverse events following therapeutic opioid administration in adults: is pharmacogenetic analysis useful?
Madadi P and Sistonen J and Silverman G and Gladdy R and Ross CJ and Carleton BC and Carvalho JC and Hayden MR and Koren G
DOI: 10.1155/2013/518012
PubMed: 23748253
2013Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy.
Madadi P and Amstutz U and Rieder M and Ito S and Fung V and Hwang S and Turgeon J and Michaud V and Koren G and Carleton BC and CPNDS Clinical Recommendations Group
PubMed: 24214521
2013Apnea and oxygen desaturations in children treated with opioids after adenotonsillectomy for obstructive sleep apnea syndrome: a prospective pilot study.
Khetani JD and Madadi P and Sommer DD and Reddy D and Sistonen J and Ross CJ and Carleton BC and Hayden MR and Koren G
DOI: 10.1007/bf03262421
PubMed: 23013460
12/2012Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: the devil is in the details.
Lam J and Matlow JN and Ross CJ and Hayden MR and Carleton BC and Madadi P
DOI: 10.1097/ftd.0b013e31825da19f
PubMed: 22777151
08/2012Economic impact of a genetic test for cisplatin-induced ototoxicity.
Dionne F and Mitton C and Rassekh R and Brooks B and Ross C and Hayden M and Carleton B
DOI: 10.1038/tpj.2011.15
PubMed: 21502965
06/2012Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
Brunham LR and Lansberg PJ and Zhang L and Miao F and Carter C and Hovingh GK and Visscher H and Jukema JW and Stalenhoef AF and Ross CJ and Carleton BC and Kastelein JJ and Hayden MR
DOI: 10.1038/tpj.2010.92
PubMed: 21243006
06/2012More codeine fatalities after tonsillectomy in North American children.
Kelly LE and Rieder M and van den Anker J and Malkin B and Ross C and Neely MN and Carleton B and Hayden MR and Madadi P and Koren G
DOI: 10.1542/peds.2011-2538
PubMed: 22492761
05/2012Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.
Visscher H and Ross CJ and Rassekh SR and Barhdadi A and Dubé MP and Al-Saloos H and Sandor GS and Caron HN and van Dalen EC and Kremer LC and van der Pal HJ and Brown AM and Rogers PC and Phillips MS and Rieder MJ and Carleton BC and Hayden MR and Canadian Pharmacogenomics Network for Drug Safety Consortium
DOI: 10.1200/jco.2010.34.3467
PubMed: 21900104
05/2012Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.
Sistonen J and Madadi P and Ross CJ and Yazdanpanah M and Lee JW and Landsmeer ML and Nauta M and Carleton BC and Koren G and Hayden MR
DOI: 10.1038/clpt.2011.280
PubMed: 22398969
04/2012Suspected opioid overdose case resolved by CYP2D6 genotyping.
Shaw KD and Amstutz U and Jimenez-Mendez R and Ross CJ and Carleton BC
DOI: 10.1097/ftd.0b013e31824a1e21
PubMed: 22406651
04/2012Apnea and oxygen desaturations in children treated with opioids after adenotonsillectomy for obstructive sleep apnea syndrome: A prospective pilot study
Pediatric Drugs
Khetani, J.D. and Madadi, P. and Sommer, D.D. and Reddy, D. and Sistonen, J. and Ross, C.J.D. and Carleton, B.C. and Hayden, M.R. and Koren, G.
DOI: 10.2165/11633570
2012Erratum: Economic impact of a genetic test for cisplatin-induced ototoxicity (The Pharmacogenomics Journal (2012) 12 (205-213) DOI: 10.1038/tpj.2011.15)
Pharmacogenomics Journal
Dionne, F. and Mitton, C. and Rassekh, R. and Brooks, B. and Ross, C. and Hayden, M. and Carleton, B.
DOI: 10.1038/tpj.2011.21
2012Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics.
Visscher H and Amstutz U and Sistonen J and Ross CJ and Hayden MR and Carleton BC
DOI: 10.1097/fjc.0b013e3182163b82
PubMed: 21386709
09/2011CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
VanderVaart S and Berger H and Sistonen J and Madadi P and Matok I and Gijsen VM and de Wildt SN and Taddio A and Ross CJ and Carleton BC and Hayden MR and Koren G
DOI: 10.1097/ftd.0b013e3182272b10
PubMed: 21743374
08/2011HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.
Warby SC and Visscher H and Collins JA and Doty CN and Carter C and Butland SL and Hayden AR and Kanazawa I and Ross CJ and Hayden MR
DOI: 10.1038/ejhg.2010.229
PubMed: 21248742
05/2011Pharmacogenomics of serious adverse drug reactions in pediatric oncology
Journal of Population Therapeutics and Clinical Pharmacology
Ross, C.J.D. and Visscher, H. and Rod Rassekh, S. and Castro-Pastrana, L.I. and Shereck, E. and Carleton, B. and Hayden, M.R.
2011Amelioration of hypertriglyceridemia with hypo-alpha-cholesterolemia in LPL deficient mice by hematopoietic cell-derived LPL.
Ding Y and Zhang L and Wang Y and Huang W and Tang Y and Bai L and Ross CJ and Hayden MR and Liu G
DOI: 10.1371/journal.pone.0025620
PubMed: 21980507
2011Pharmacogenomics of serious adverse drug reactions in pediatric oncology.
Ross CJ and Visscher H and Rassekh SR and Castro-Pastrana LI and Shereck E and Carleton B and Hayden MR
PubMed: 21467604
2011The communication of pharmacogenetic research results: Participants weigh in on their informational needs in a pilot study
Journal of Population Therapeutics and Clinical Pharmacology
Madadi, P. and Joly, Y. and Avard, D. and Chitayat, D.C. and Smith, M.A. and Ross, C.J.D. and Carleton, B.C. and Hayden, M.R. and Koren, G.
2011Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.
Madadi P and Joly Y and Avard D and Chitayat DC and Smith MA and Ross CJ and Carleton BC and Hayden MR and Koren G
DOI: 10.1038/clpt.2010.125
PubMed: 20739920
12/2010Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.
Madadi P and Hildebrandt D and Gong IY and Schwarz UI and Ciszkowski C and Ross CJ and Sistonen J and Carleton BC and Hayden MR and Lauwers AE and Koren G
DOI: 10.1542/peds.2009-1907
PubMed: 20837591
10/2010Pharmacogenomics and active surveillance for serious adverse drug reactions in children.
Loo TT and Ross CJ and Sistonen J and Visscher H and Madadi P and Koren G and Hayden MR and Carleton BC
DOI: 10.2217/pgs.10.111
PubMed: 20860467
09/2010Ultrasound-guided sacroiliac joint injection in patients with established sacroiliitis: precise IA injection verified by MRI scanning does not predict clinical outcome.
Hartung W and Ross CJ and Straub R and Feuerbach S and Schölmerich J and Fleck M and Herold T
DOI: 10.1093/rheumatology/kep424
PubMed: 20019067
08/2010The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
Ross CJ and Visscher H and Sistonen J and Brunham LR and Pussegoda K and Loo TT and Rieder MJ and Koren G and Carleton BC and Hayden MR and CPNDS Consortium
DOI: 10.1089/thy.2010.1642
PubMed: 20578893
07/2010Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
Archives of pediatrics & adolescent medicine
Oberlander TF and Papsdorf M and Brain UM and Misri S and Ross C and Grunau RE
DOI: 10.1001/archpediatrics.2010.51
PubMed: 20439795
05/2010The importance of XRCC2 in RAD51-related DNA damage repair.
Tambini CE and Spink KG and Ross CJ and Hill MA and Thacker J
DOI: 10.1016/j.dnarep.2010.01.016
PubMed: 20189471
05/2010Perceptions about self-management among people with severe asthma.
Ross CJ and Williams BA and Low G and Vethanayagam D
DOI: 10.3109/02770901003611462
PubMed: 20394519
04/2010Cases: Cocaine adulterant linked to neutropenia.
Wiens MO and Son WK and Ross C and Hayden M and Carleton B
DOI: 10.1503/cmaj.090286
PubMed: 19969562
01/2010Glucose intolerance and decreased early insulin response in mice with severe hypertriglyceridemia.
Experimental biology and medicine (Maywood, N.J.)
Ding YL and Wang YH and Huang W and Liu G and Ross C and Hayden MR and Yang JK
DOI: 10.1258/ebm.2009.009100
PubMed: 20404017
01/2010Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results.
Jung EM and Ross CJ and Rennert J and Scherer MN and Farkas S and von Breitenbuch P and Schnitzbauer AA and Piso P and Lamby P and Menzel C and Schreyer AG and Feuerbach S and Schlitt HJ and Loss M
DOI: 10.3233/ch-2010-1336
PubMed: 21135485
2010Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
American Heart Journal
Baigent, C. and Landray, M. and Reith, C. and Dasgupta, T. and Emberson, J. and Herrington, W. and Lewis, D. and Mafham, M. and Collins, R. and Bray, C. and Chen, Y. and Baxter, A. and Young, A. and Hill, M. and Knott, C. and Cass, A. and Feldt-Rasmussen, B. and Fellström, B. and Grobbee, R. and Grönhagen-Riska, C. and Haas, M. and Holdaas, H. and Hooi, L.S. and Jiang, L. and Kasiske, B. and Krairittichai, U. and Levin, A. and Massy, Z. and Tesar, V. and Walker, R. and Wanner, C. and Wheeler, D. and Wi?cek, A. and Majoni, W. and Simpson, D. and Strony, J. and Musliner, T. and Agodoa, L. and Armitage, J. and Chen, Z. and Craig, J. and De Zeeuw, D. and Gaziano, M. and Grimm, R. and Krane, V. and Neal, B. and Ophascharoensuk, V. and Pedersen, T. and Sleight, P. and Tobert, J. and Tomson, C. and Sandercock, P. and Keech, A. and Whelton, P. and Yusuf, S. and Peto, R. and Parish, S. and Dolph, L. and Bahu, T. and Booth-Davey, E. and Brewster, A. and Yau, F. and Denis, E. and Frederick, K. and Haywood, D. and Heineman, J. and Howard, S. and Jayne, K. and Madgwick, Z. and Michell, S. and Murphy, K. and Ning, L. and Nolan, J. and Nunn, M. and Roberts, J. and Wickman, M. and Bowman, L. and Bulbulia, R. and Haynes, R. and Rahimi, K. and Rahman, N. and Ait-Sadi, R. and Barton, I. and Zhu, W. and Clark, S. and Kourellias, K. and Radley, M. and Brown, K. and Worthing, D. and Coates, G. and Goodenough, B. and Lucas, N. and Carreras, A. and Currie, R. and Donaldson, O. and Fjalling, E. and Gallagher, M. and Gibson, K. and Goddard, J. and Healy, J. and Hones, L. and Jardine, M. and Kwong, I. and Merai, M. and Murray, S. and Perkovic, V. and Rendina, A. and Gallo, K. and Caron, S. and Carlson, K. and Foley, K. and Matzek, S. and Mewhort, L. and O'Donoghue, S. and Perel-Winkler, A. and Terins, T. and Nie, Q. and Yu, H. and Ge, L. and Hao, D. and Li, L. and Pang, X. and Wei, X. and Yan, G. and Certikova Chabova, V. and Holst, H. and M?lvadgaard, T. and Munksgaard, D. and Peltonen, Y. and Liabeuf, S. and Lebel, C. and Ouabou, L. and Bauer, B. and Bergmann, K. and Beusch, M. and Cavitt, D. and Drechsler, C. and Dulau, I. and Hügen, K. and Kempf, S. and Kuchenmeister, B. and Küllmer, S. and Pscheidl, V. and Schmiedeke, D. and Schwarz, M. and Speerschneider, K. and Stahl, B. and Lim, B.C. and Nadia, H. and Zishareena, M.F. and Vasuthavan, S. and Ganesapillai, A.T. and Yuen, S. and Grobbee, D. and Bobbink, I. and Groot, K. and Sikking, I. and Raley, J. and Colban, M. and Smerud, K. and Trygg, N. and Waagaard, E. and Westad, H. and Rotkegel, S. and Spiechowicz, U. and Domoradzka, M. and Gaw?owska, M. and Flygar, A. and Ödmark, I. and Pettersson, A. and Blackwood, S. and Barclay, J. and Benham, J. and Brown, R. and Cureton, L. and Jackson, D. and Kennedy, I. and Leaper, C. and Taylor, A. and Winter, C. and Wise, C. and Nash, M. and Taylor Bennett, A. and Donaldson, D. and Chalmers, K. and Corderoy, H. and Bartkoske, M. and Bjerk, C. and Camarena, A. and Herskovitz, L. and Heuer, C. and Levin, J. and Robinson, R. and Wicklund, B. and Bentzel, D. and Cohen, S. and Costa, C. and Scranton, R. and Auwardt, R. and Boyer, M. and Cogdell, P. and Menahem, S. and Sheldrake, J. and Mount, P. and Fraenkel, M. and Bisscheroux, P. and Dempester, J. and Gleeson, P. and Harris, G. and Holmes, C. and Hyett, K. and Linton, A. and Miach, P. and Booth, D. and Druce, L. and Mantha, M. and Borg, E. and Green, S. and Killen, J. and Lynch, Y. and Colquhoun, D. and Herzig, K. and Row, G. and Addison, J. and Asa, J. and Beatson, G. and Calvird, D. and Edmunds, J. and Ferreira-Jardim, A. and Gwynne, A. and Mackay, D. and McLoughlin, L. and Wightwick, C. and Williams, L. and Ferrari, P. and Barry, J. and Hodson, S. and Zakrzewska, W. and Meagher, E. and Mulcahy, M. and Parnham, A. and Carney, S. and Garvey, L. and Gillies, A. and Hayes, S. and Mathew, M. and Fassett, R. and Anderson, L. and Clingeleffer, C. and Curnock, A. and Mayne, L. and Richardson, D. and Smith, M. and Smith, S. and Suranyi, M. and Howlin, K. and Chow, J. and Cleland, B. and Rayment, G. and Spicer, T. and Wong, J. and Wong, M. and Packham, D. and Alison, C. and Fraser, I. and Mitchell, J. and Nagle, J. and Brown, F. and Ellery, C. and Monkhouse, J. and Nandkumar, J. and Reith-Myers, L. and Gray, N. and Cocks, C. and Courtney, M. and Hollett, P. and Johnston, C. and Larsen, H. and Pollock, A. and Stewart, S. and Styles, G. and Wyndham, R. and Fanning, M. and Gibson, W. and Jackson, S. and Mannering, M. and Mercado, E. and Oliphant, R. and Sud, K. and Ubera, N. and Wood, C. and Karrasch, J. and Brinkley, T. and Estensen, K. and Moroney, A. and Sutton, J. and Warren, R. and Saltissi, D. and Jahke, H. and Roach, H. and Saltissi, J. and Wiederroth O'Brien, M. and Johnson, D. and Bali, V. and Evans, M. and Franzen, K. and Halbish, S. and Helyar, J. and Martin, A. and Mudge, D. and Sonnenburg, K. and Sudak, J. and Roger, S. and Almeida, S. and Andrews, H. and Bohringer, L. and Bouwhuis, L. and Brady, L. and Carpenter, A. and Warren, S. and Elias, T. and Bannister, K. and Chew, G. and Clarke, J. and Faull, R. and Hooper, A. and Jeffs, L. and Napier, A. and Peh, C. and Pirone, K. and Skilton, F. and Ranganathan, D. and Best, J. and Hart, L. and Healy, H. and Morgan, C. and Ratanjee, S. and Salisbury, A. and Jose, M. and Freeman, J. and Hamilton, R. and Kirkland, G. and Read, G. and Anderson, H. and Boekel, K. and Farrell, M. and Foreman, A. and Iliev, K. and Pedagogos, E. and Raspudic, T. and Pollock, C. and Cooper, B. and Kesselhut, J. and Macadam, C. and Pearse, J. and Rowland, C. and Tully, H. and Irish, A. and Dogra, G. and Coutts, P. and Hayes, L. and Khoo, D. and Nathoo, B. and Shakespeare, K. and Warger, A. and Gillin, A. and Burman, J. and George, C. and Sherwood, S. and Snelling, P. and Stevens, C. and Hutchison, B. and Luxton, G. and Devenny, N. and Herson, H. and Pellicano, S. and Kelly, J. and Coutelas, J. and Garlinge, C. and McClelland, A. and Pirabhahar, S. and Saleh, H. and Langham, R. and Englebright, B. and Giang, M. and Lanteri, M. and Mullins, K. and Turner, C. and Collett, P. and Stokoe, S. and Sutherland, K. and Talafua, D. and Talaulikar, G. and Clarkson, A. and Rees, C. and Carney, G. and Falk, M. and Gracey, D. and Jadeer, A. and Johnson, P. and Karpe, K. and Singer, R. and Walters, G. and McDonald, S. and Burgess, J. and Fischer, K. and Gentgall, M. and Hockley, M. and Veitch, D. and De Jersey, P. and Gillam, A. and Hartig, V. and Holland, K. and McArdle, J. and Washington, W. and Rangan, G. and Mikaheal, M. and Murie, P. and Perez, N. and Punnoose, N. and Smolonogov, T. and Taler, N. and Williams, G. and Wen, C. and Kohlhagen, J. and Wessels, J. and Johnson, S. and Reid, A. and Ryan, J. and Taprell, D. and Auinger, M. and Eigner, M. and Kodras, K. and Leithner, C. and Magpantay, L. and Marterer, C. and Prager, R. and Prinz, C. and Seiringer, E. and Kramar, R. and Mitter, E. and Stummvoll, H. and Dieplinger, G. and Wenzel, R. and Stolz, G. and Dröse, S. and Edlinger, E. and Headlam-Leitner, E. and Miska, H. and Then, M. and Weninger, S. and Lhotta, K. and Neyer, U. and Dickie, H. and Smodek, S. and Sprenger-Mähr, H. and Rosenkranz, A. and Zitt, E. and Mayr, B. and Schinner, A. and Soltys, G. and Bégin, V. and Brunet, S. and Cournoyer, S. and Gelinas, M. and Giroux, C. and Martineau, J. and Roy, M. and Savoie, L. and Agharazii, M. and Blouin, J. and Desmeules, S. and Langlois, S. and Samson, F. and Wong, G. and Constantini, L. and Jing, J. and Malko, J. and Rivers, C. and Rochester, D. and Skilling, C. and Wadgymar, A. and Wu, G. and Kates, D. and Husch, J. and Mantle, M. and Turri, L. and Barrett, B. and Curtis, B. and Greeley, B. and Hannaford, M. and Harnett, J. and Kelly, M. and Langille, E. and Morgan, J. and Murphy, S. and Karim, M. and Arbo, T. and Carpenito, G. and Chan, V. and DaRoza, G. and Friesen, M. and Kraus, D. and Lam, S. and Lange, B. and Minhas, S. and Starko, R. and Torng, S. and Vela, K. and Madore, F. and Roy, P. and Troyanov, S. and Bonnardeaux, A. and Lauzon, L. and Pichette, V. and Yeates, K. and Mahoney, K. and Myers, C. and Pilkey, R. and Moist, L. and Edgar, M. and House, A. and Kortas, C. and Mindorff, S. and Tam, P. and Chow, S. and Fung, J. and Nagai, G. and Ng, P. and Sikaneta, T. and Ting, R. and Forzley, B. and Clouatre, Y. and Cooper, S. and DaCosta, H. and Granger, S. and Valley, S. and Karunakaran, S. and Abdulhadi, M. and Altwasser, C. and Anderson, S. and Bergquist, L. and Wijeyesinghe, C. and Berst, L. and Horgan, K. and Coles, K. and Lotter, T. and Robson, L. and Barre, P. and Golden, J. and Golden, M. and Tanguay, N. and Rigatto, C. and Armstrong, S. and Fine, A. and Fontaine, B. and Friesen, D. and Henry, S. and Kraushar, M. and Reslerova, M. and Verrelli, M. and Rabbat, C. and Clase, C. and Suva, G. and Winegard, N. and Goldstein, M. and Curvelo, S. and Donnelly, S. and Huckle, J. and Marticorena, R. and Chan-Yan, C. and Chiu, A. and DeLuca, L. and Flamer, D. and Gill, J. and Jamal, A. and Jung, B. and Kiaii, M. and Landsberg, D. and Rozen, N. and Taylor, P. and Werb, R. and Pylypchuk, G. and Ahmed, A. and Barton, J. and Hundseth, M. and Kappel, J. and Keindel, I. and Klassen, J. and Pylypchuk, S. and Rindall, M. and Tobe, S. and Naimark, D. and Agelopoulos, M. and Chessman, M. and Hladunewich, M. and Perkins, N. and Sainsbury, S. and McCready, W. and Adams, B. and Tonelli, M. and Caldwell, S. and Kumar, U. and McMahon, A. and Nikitin, S. and Restall, J. and Treit, S. and Wysocki, Y. and Duncan, J. and Copland, M. and Jastrzebski, J. and Keown, P. and Kwan, S. and Rogers, D. and Shapiro, J. and Singh, S. and Sioson, L. and Yee, K. and Yeung, C. and Zacharias, J. and Bueti, J. and Dizon, B. and Lam, H. and Miller, L. and Ross, M. and Zarrillo, M. and Li, Z. and Wang, C. and Liu, L. and Hong, M. and Zheng, H. and Zuo, W. and Ge, Z. and Liu, Q. and Li, Y. and Sun, K. and Zhao, R. and Sun, G. and Wang, F. and Cui, Z. and Lou, F. and Du, Y. and Song, L. and Huang, H. and Song, Z. and Wang, J. and Zhou, L. and Wu, R. and Xiao, R. and Zhang, Q. and Duan, N. and Ju, N. and Wang, A. and Xu, Z. and Lu, Z. and Zhang, Y. and Zhao, L. and Zhang, C. and Mo, Z. and Xie, Y. and Xiong, J. and Chen, J. and Guo, L. and Zhao, S. and Peiskerova, M. and Jancova, E. and Kazderova, M. and Kobrova, L. and Gorun, P. and Kmentova, T. and Burgelova, M. and Lyerova, L. and Viklicky, O. and Berdych, M. and Nydlova, Z. and Jelinkova, G. and Molta?, J. and Pauzar, T. and Knetl, P. and Cahova, J. and Simkova, J. and Zakova, M. and Vankova, S. and Safarova, R. and Hruby, M. and Karlova, R. and Prikaska, V. and Sellenberg, P. and Vesela, E. and Malanova, L. and Vlasak, J. and Kaprova, P. and Novakova, D. and Kotherova, K. and Studenovska, M. and Christensen, J. and S?lling, J. and Jepsen, M. and Kristensen, V. and Aerenlund, H. and Br?mer-Jensen, M. and Kamper, A. and Raaschou, S. and Heaf, J. and Dreyer, J. and Freese, P. and Holm, M. and Munch, M. and Gade-Rasmussen, E. and Bredmose, K. and Daugaard, H. and Nielsen, J. and Friedberg, M. and Jensen, D. and Munk Plum, M. and Solling, K. and Dieperink, H. and Arp Nielsen, L. and Friborg, E. and Gloe-Jakobsen, A. and Thye Ronn, P. and Rasmussen, K. and Andersen, C. and Johansen, A. and Odum, L. and Ostergaard, O. and Pedersen, L. and Lykkegaard, S. and Aundal, M. and Faureholm Huess, S. and Danielsen, H. and Madsen, J. and Nyvang, M. and Ekstrand, A. and Boman, H. and Hartman, J. and Lipponen, A. and Lithovius, R. and Rauta, V. and Salmela, A. and Saloranta, K. and Forslund, T. and Koskiaho, P. and Jaaskelainen, K. and Kanninen, M. and Laine, K. and Asola, M. and Huhti, J. and Pentti, M. and Metsarinne, K. and Heiro, M. and Koivuviita, N. and Saarinen, M. and Tertti, R. and Choukroun, G. and Fournier, A. and Ducloux, D. and Marechal, F. and Simula Faivre, D. and Combe, C. and Douillet, M. and Lamblot, T. and Nardi, H. and Vendrely, B. and Bourbigot, B. and Ferlandin, S. and Zaoui, P. and Jouet, C. and Geffroy-Guiberteau, S. and Bugnazet, L. and Aldigier, J. and El Hamel-Belili, C. and Giraud, S. and Dussol, B. and Berland, Y. and Chollet, M. and Sichez, H. and Cristol, J. and Canaud, B. and Morena, M. and Rodriguez, A. and Kessler, M. and Mizejewski, B. and Risse, B. and Urena Torres, P. and Bou-Bekr, M.A. and Arezki, C. and Ras El Qdim, P. and Vela, C. and Borsato, F. and Talairach, A. and Normand, M. and Normand, V. and Rieu, P. and Gauthier, B. and Vigneron-Foy, C. and Wolak, A. and Menoyo, V. and Alos, L. and Caillette-Beaudoin, A. and Berger, V. and Al-Sarraf, S. and Konnerth, I. and Urban, C. and Weiner, S. and Boesken, W. and Jochum, E. and Kiefer, C. and Wagner, A. and Krumme, B. and Bohler, J. and Bonow, B. and Hohenstatt, U. and Mettang, T. and Rockel, A. and Langanke, J. and Lipponer, H. and Dunschen-Weimar, G. and Dunst, R. and Hubel, E. and Petrik, R. and Rengel, R. and Schmidgen, M. and Mayr, H. and Garschhammer, C. and Weirauch, S. and Anger, H. and Goock, T. and Mai, A. and Bast, I. and Suptitz, C. and Iwig, B. and Florschutz, K. and Haßelbacher, R. and Sauerbrey, G. and Delrieux, S. and Rau, S. and Poley, M. and Laux, R. and Schonfelder, O. and Kunowski, G. and Fuchs, G. and Hoffmann, K. and Schurger, R. and Brensing, K. and Guven, Z. and Immenkamp, C. and Kottmann, C. and Schmitt, H. and Schulz, M. and Arnold, P. and Knaup, R. and Schneider, H. and Siemsen, H. and Pyriki, P. and Korkemeyer, F. and Pyriki, R. and Siebrecht, A. and Schulz, E. and Krumwiede, A. and Kruse, D. and Lucke, S. and Keim, H. and Fink, H. and Fischer, S. and Klingbeil, A. and Kuhlmei, K. and Ortwein-Horn, N. and Merker, L. and Bayer, B. and Benamar, K. and Emmert, S. and Floten, E. and Holzheuer, K. and Lummer, M. and Ossendorf, E. and Scholz, M. and Oppitz, M. and Georgiew, L. and Tripps, C. and Wendehake, M. and Lange, D. and Pingel, V. and Brause, M. and Schanze, W. and Duygulu, E. and Dellanna, F. and Heinemann-Nieberding, S. and Sturmer, C. and Wieczorek, K. and Zarga, O. and Kullmer, B. and Kullmer, S. and Akin, M. and Gondolf, M. and Schutterle, S. and Walker, G. and Bertsch, R. and Seul, M. and Allendorff, J. and Siehler, R. and Stemmler, S. and Baldus, M. and Adler, A. and Harter, S. and Wurmell, W. and Moller, M. and Hame, C. and Muller, M. and Schreiber, M. and Schurfeld, C. and Millington-Herrmann, M. and Benschneider, A. and Gaffal, J. and Sprunken, U. and Bohling, M. and Wunderlich, S. and Schramm, L. and Kollenbrath, C. and Netzer, K. and Sieber, T. and Zimmermann, J. and Bellersen, M. and Uerkvitz, M. and David-Walek, T. and Hauschildt, B. and Leimenstoll, G. and Lonnemann, G. and Hilfenhaus, M. and Benedetto, C. and Stockmann, S. and Ichtiaris, P. and Jungmann, A. and Neumeier, K. and Stoof, A. and Bohmer, K. and Kirpal, A. and Knogl, A. and Flege, F. and Franke, K. and Groth, P. and Parensen, E. and Bockmann, M. and Przyklenk, P. and Piazolo, L. and Thinius-Jaudas, L. and Versen, A. and Hettich, R. and Arendt, R. and Geiger, K. and Hoppe, H. and Schwarting, A. and Beyer, T. and Faust, J. and Hazenbiller, A. and Tschirner, S. and Grupp, C. and Dorsch, O. and Eigner-Schmidtchen, M. and Michler, K. and Roth, J. and Schramm, S. and Waldmuller, G. and Riedl, B. and Vogele-Dirks, H. and Linz, J. and Biggar, P. and Hennemann, H. and Bauer, G. and Buchholz, J. and Fischer, P. and Bihlmaier, W. and Baumann, A. and Peichl, B. and Roser, S. and Ludewig, S. and Ricksgers, M. and Szendzielorz, M. and Baus, A. and Baust, K. and Schaller, P. and Schnellbacher, G. and Sorensen, S. and Buschges-Seraphin, B. and Hauenstein, L. and Hofmann, B. and Nikolay, J. and Merkel, F. and Nebel, M. and Petersen, J. and Schweb, S. and Zeißler, H. and Baumhackel, K. and Krauß, A. and Schafer, R. and Pastor, A. and Zielinski, B. and Strauß, H. and Theis, H. and Burkhardt, K. and Heckel, M. and Hussendorfer, K. and Bahner, U. and Brandl, M. and Hammerl-Kraus, B. and Herrmann, D. and Kramer, H. and Baudenbacher, H. and Blaser, C. and Buschmann, G. and Eckert, G. and Ehrich, H. and Hofmann, K. and Huller, U. and Geiger, H. and Becker, B. and Hoischen, S. and Bartel, C. and Hennig, J. and Obermuller, N. and Schulte, C. and Fischereder, M. and Burchardi, F. and Rupprecht, H. and Weidner, S. and Anders, H. and Andriaccio, L. and Lederer, S. and Ricken, G. and Straßer, C. and Lammert, A. and Schmitt, W. and Van Der Woude, F. and Langhauser, B. and Markau, S. and Osten, B. and Thiemicke, D. and Dorligschaw, O. and Weickert, M. and Breunig, F. and Denninger, G. and Osiek, S. and Rebstock, W. and Schulz, P. and Swoboda, F. and De Cicco, D. and Harlos, J. and Lebert, A. and Riegel, M. and Schmiedeke, T. and Hoffmann, U. and Nolle, M. and Jankrift, P. and Pfleiderer, H. and Witta, J. and Wittler, B. and Luth, J. and Dumann, H. and Habel, U. and Torp, A. and Sehland, D. and Tieß, M. and Etzold, C. and Friederiszik, A. and Morgenroth, A. and Dybala, A. and Suffel, A. and Leimbach, T. and Kron, J. and Sauer, S. and Meyer, T. and Meyer, M. and Lammers, U. and Bekman, J. and Holtz, S. and Kausler-Book, B. and Stobbe, S. and Hohage, H. and Heck, M. and Schulte, F. and Welling, U. and Zeh, M. and Seyfried, J. and De Heij, T. and Menzinger, A. and Weinreich, T. and Hopf, M. and Groll, J. and Kammholz, K. and Peters, K. and Schwietzer, G. and Kreft, B. and Weibchen, U. and Voßkuhler, A. and Hollenbeck, M. and Klaue, K. and Rzepucha, E. and Sperling, K. and Seeger, W. and Weyer, J. and Heine, C. and Kirste, P. and Zemann, B. and Alscher, D. and Rumpf, D. and Wullen, B. and Bengel, A. and Friedrich, B. and Kirschner, T. and Knodler, U. and Machleidt, C. and Niederstrasser, K. and Noack, E. and Wilhelm, J. and Heuer, H. and Dulea, J. and Piolot, R. and Rudke, M. and Treinen, G. and Elberg, B. and Hanke, J. and Nitschke, T. and Rosendahl, C. and Schmitz, A. and Schrader, J. and Kulschewski, A. and Lubcke, C. and Hammersen, F. and Luders, S. and Venneklaas, U. and Muhlfeld, A. and Arabi Al-Khanne, F. and Ketteler, M. and Politt, D. and Schuster, C. and Eitner, F. and Goretz, U. and Heidenreich, S. and Janssen, U. and Kranz, A. and Moormann, E. and Schneider, B. and Weber, W. and Frei, U. and Jovanovic, T. and Asmus, H. and Canaan-Kuhl, S. and Pannier, L. and Petersen, S. and Pluer, M. and Schaeffner, E. and Schafer, C. and Warncke, S. and Schmieder, R. and Donhauser, C. and Schulze, B. and Koziolek, M. and Bechtel, W. and Kurz, B. and Strutz, F. and Bramlage, C. and Dreyer, S. and Mommeyer, E. and Niemann, J. and Scheel, A. and Troche-Polzien, I. and Weber, F. and Heine, G. and Girndt, M. and Lizzi, F. and Rogacev, K. and Lindner, T. and Achenbach, H. and Peschel, K. and Beige, J. and Jentho, S. and Kreyßig, C. and Prill, K. and Renders, L. and Walcher, J. and Cerny, S. and Fulbier, A. and Kristen, H. and Nitschke, M. and Kramer, J. and Marek, P. and Meier, M. and Schlieter, J. and Heyne, N. and Bachmann, F. and Faber, M. and Klipp, K. and Kustner, U. and Risler, T. and Rath, T. and Ruf, T. and Budiman, D. and Seidel, C. and Weik, S. and Teo, S.M. and Lee, L.Y. and Azizah, H. and Faridunishah, S.A. and Foo, S.M. and Go, K.W. and Ghazali, A. and Koh, K.H. and Zaki, M. and Wong, H.S. and Bavanandan, S. and Boey, L.M. and Lily, M. and Wong, S.L. and Rosnawati, Y. and Zawawi, N. and Azimawati, A. and Hindun, A. and Hasnah, J. and Korina, R. and Yunaidah, A. and Noraidah, P. and Ong, L.M. and Noor Asma, A. and Liew, Y.F. and Rozina, G. and Cheong, Y.H. and Ang, A.H. and Dayang, J. and Lim, L.S. and Sukeri, M. and Ramli, S. and Zulkifli, M. and Wan Mahmood, W.K. and Goh, B.L. and Sarifah, B. and Bee, B.C. and Ramasamy, C. and Ruszarimah, S. and Liu, W.J. and Razali, O. and Haslinah, S. and Vaithilingam, I. and Jaaini, A. and Faridah, L. and Ng, K.H. and Krishnan, P. and Rosnah, A.A. and Nor Azizah, A.S. and Tam, C.C. and Tan, S.H. and Tan, C.C. and Shahnaz, F.K. and Wazir, H. and Munusamy, P. and Wan Shaariah, M.Y. and Chew, T.F. and Fuziah, Z. and Tan, C.H.H. and Maria, L. and Javelin, P. and Lim, S.K. and Nazatul, S.B. and Engkasan, L.P. and Tan, S.Y. and Wong, M.G. and Julita, A.A. and Ang, B.B. and Krishnan, S. and Seet, W.W.T. and Liew, S.K. and Keng, T.C. and Tobé, T. and Deelen, M. and Klaassen, I. and Grave, W. and Emmen, M. and Janssen, W. and Bossen, W. and Elzinga, B. and Van Der Velden, A. and Hemmelder, M. and Slagman, M. and Waanders, F. and Viergever, P. and Boerema, I. and Potter Van Loon, B. and Muthert, B. and Geers, T. and Schollaert, N. and Van Weverwijk, I. and Veen, P. and Woittiez, A. and Krikken, J. and Kwakernaak, A. and Visser, F. and Navis, G. and Hoekstra, F. and Hawkins, S. and McGregor, D. and Usher, J. and MacGinley, R. and Schollum, J. and Ellis, G. and Voss, D. and Rosman, J. and Upjohn, M. and Panlilio, N. and Madhan, K. and Naicker, V. and Anderson, E. and Bushell, M. and Lumb, N. and Pepperell, B. and Sizeland, P. and Hayett, S. and Sullivan, N. and Tuffery, C. and Macdonald, A. and Ostapowicz, T. and Wessel-Aas, T. and Wessel-Aas, H. and Bj?rb?k, E. and Bj?rb?k, R. and Sims?, I. and ?ien, C. and Bergrem, H. and Espedal, S. and Kronborg, J. and Solbakken, K. and Rocke, J. and Aakervik, O. and Haugen, V. and Eide, T. and Berglund, J. and L?land, W. and Schei, T. and Str?ms?ther, C. and Willadsen, H. and Lyngdal, P. and Vad, A. and Waldum, B. and Fr?slid, G. and Roaldsnes, C. and Rustad, D. and Söderblom, P. and Eriksen, B. and Hanssen, E. and Julsrud, J. and Mathisen, U. and Pedersen, M. and Rumsfeld, M. and Toft, I. and Berget, K. and Landsverk, K. and Tveiten, G. and Wamstad, H. and Klinger, M. and Krajewska, M. and Golebiowski, T. and Kusztal, M. and Spiechowicz-Zaton, U. and Rutkowski, B. and Renke, M. and Tylicki, L. and Czekalski, S. and Koziol, L. and Wanic-Kossowska, M. and Wasik-Olejnik, A. and Nowicki, M. and Dryja, P. and Kurnatowska, I. and Zawiasa, A. and Ciszek, M. and Gomólka, M. and Mysliwiec, M. and Brzósko, S. and Mazerska, M. and Hruby, Z. and Koscielniak, K. and Stanek-Piotrowska, M. and Mesjasz, J. and Rudka, R. and Barañski, M. and Jupowiecki, J. and Klein, D. and Switalski, M. and Kuriga, M. and Ostrowski, M. and Lidman, ?. and Linde, T. and Waltersson, K. and Weiss, L. and Andersson, G. and Lindell, C. and Welander, G. and Jacobson, S. and Edensjö, P. and Wallin, J. and Linder, M. and Karsberg, M. and Hellgren, K. and Lönn, I. and Frisenette-Fich, C. and Johansson, A. and Lundström, A. and Mauritz, N. and St?hl-Nilsson, A. and Tobafard, N. and Hellberg, O. and Ejemar, E. and Von Schmalensee, N. and Gunne, T. and Eriksson, A. and Östberg, S. and Svensson, C. and Mulec, H. and Jacobsson, A. and Karlsson, M. and Önnermalm, L. and Osagie, S. and Ekengren, U. and Larsson, M. and Lindberger, K. and Olofsson, A. and Samuelsson, O. and Beagan, L. and Dezfoolian, H. and Just, M. and Örtegren, L. and Saeed, A. and Strand, U. and Ramsauer, B. and Hultström, D. and Nordlinder, K. and Sundberg, I. and Öqvist, B. and Green, C. and Fernström, A. and Cassel, A. and Göransson, I. and Gylling, M. and Jörgensen, A. and Sterner, G. and Christensson, A. and Hjelmstedt, P. and Nyström, A. and Sundin, P. and Samuelsson, I. and Tidman, M. and Johansson, M. and Löfgren Andersson, M. and Öhman, M. and Andersson, P. and Hallberg Karlsson, A. and Ringstad, L. and Chittinandana, A. and Chailimpamontree, W. and Gojaseni, P. and Singprasert, R. and Tungsanga, K. and Amphun, W. and Intim, P. and Kanjanabuch, T. and Poowarattanakul, D. and Treratha, C. and Wongvan, P. and Jittikanont, S. and Suriya, T. and Indrasthitya, P. and Sumethkul, V. and Ingsathit, A. and Jansomwong, J. and Lertchalorarn, K. and Phachiyanukul, V. and Phiromkit, T. and Saengsri, S. and Vareesangthip, K. and Chawanasuntorapoj, R. and Kiattisunthorn, K. and Larpkitkachorn, R. and Webster, J. and Henderson, J. and Jayne, D. and Hollis, J. and Townsend, K. and Harron, C. and Bleakley, N. and Hanley, N. and Morgan, S. and Brittney, L. and Brown, H. and Maxwell, P. and Murtagh, H. and Thomas, M. and Burke, E. and Carmody, M. and Cox, G. and Dasgin, J. and Ali, G. and Whitehouse, L. and Williams, V. and Brown, E. and Dlelana, G. and Esson, A. and Fagerbrink, S. and Marshall, F. and Mazibuko, B. and Nelson, C. and Russell, E. and Williams, R. and Altmann, P. and McNichols-Thomas, C. and Parsons, K. and MacGregor, M. and McGowan, J. and Mead, P. and Gilbanks, K. and Sanderson, M. and Fluck, R. and Chandler, G. and Hulme, L. and Smith, J. and Tse, Y. and West, C. and Taylor, J. and Breakspear, S. and Burgess, B. and Isles, C. and Bell, J. and Duignan, J. and Gorman, J. and Swainson, C. and Beveridge, C. and Cairns, A. and Miller, D. and Paterson, F. and Smith, L. and Kumwenda, M. and Glover, R. and Geddes, C. and Gemmell, C. and Grieve, I. and Matthews, E. and McLaren, B. and Meyer, B. and Spiers, A. and Banks, R. and Apperley, P. and Patterson, T. and Paynter, H. and Scoble, J. and Thom, D. and Watkins, J. and Kalra, P. and Gowland, S. and Haydock, L. and Smart, I. and Bhandari, S. and Gillett, P. and James, K. and Lewis, R. and Melville, H. and Tamimi, A. and Williams, P. and Heath, T. and Small, S. and Paterson, A. and Gibson, N. and Laven, C. and Reaich, R. and Wilson, T. and Cairns, H. and Casley-Ready, K. and Warwick, G. and Fentum, B. and James, J. and Kumar, T. and Marshall, R. and Ratcliffe, F. and Shenton, A. and Warwicker, P. and Bowser, M. and Mumford, C. and Mitra, S. and Woolfson, R. and Yang, R. and Williams, A. and Richards, K. and Turner, A. and Odum, J. and Rylance, P. and Smallwood, A. and Ward, J. and Henderson, I. and McMahon, M. and Ross, C. and Burrows, M. and Morais, J. and Rajan, S. and Tindall, H. and Barrett, C. and Kelly, F. and El-Nahas, M. and Bartholomew, J. and Edwards, L. and Okhuoya, F. and Bebb, C. and Cassidy, M. and Brand, S. and Quashie-Howard, M. and Taggart, C. and Capps, N. and Tonks, L. and Mason, J. and Powell, S. and Watkins, L. and Ball, S. and Dutton, M. and Fifer, L. and McGlynn, F. and Wood, M. and Jenkins, D. and Allan, N. and Fahal, I. and Elhag-Ali, H. and King, J. and Peel, R. and Potts, L. and Logie, I. and McGhie, F. and Naik, R. and Parry, R. and Andain, K. and Durkin, S. and D'Souza, R. and Harrison, D. and Cooke, J. and Kinyanjui, R. and Harper, J. and Algate, K. and McCarthy, M. and Van Eker, D. and Thuraisingham, R. and Chinodya, M. and Deelchand, V. and Garcia, R. and Ngango, R. and Rolfe, C. and Williams, K. and Solomon, L. and Heap, T. and MacDowall, P. and Saunderson Smith, L. and MacDiarmaid-Gordon, A. and Harman, W. and Smithson, H. and Robertson, D. and Gammon, B. and O'Grady, D. and Verow, C. and Rogerson, M. and Berry, L. and Gough, C. and Hayward, E. and Jones, C. and Payne, T. and Rowe, L. and Sibley, C. and Szymanski, J. and Almond, M. and Bourton, L. and Bromwich, C. and Dawson, S. and Mason, S. and Oliveira, D. and Ramkhelawon, R. and Tuazon, J. and Andrews, P. and Archer, K. and Moore, A. and Thomas, G. and Velazquez, C. and Mumtaz, R. and Roberts, R. and Farquhar, F. and Ott, J. and Fenwick, S. and Callaway, A. and Garrett, P. and Dees, L. and McDonagh, U. and Garner, S. and Zehnder, D. and Aldridge, N. and Dyer, C. and Gomez, M. and Hewins, S. and McCarthy, K. and Rush, J. and Spencer, S. and Harvey, M. and Mills, H. and Drew, P. and Henry, M. and Wilberforce, S. and Worth, D. and Adair, Z. and Hartley, J. and Jibani, M. and Jones, D. and Swan, S. and Shamp, T. and Alcorn, H. and Bookey, J. and Cannon, C. and Jarvis, K. and Muesing, C. and Murphy, M. and Muster, H. and Planting, M. and Strand, C. and Middleton, J. and Gitter, K. and Mace, N. and Schumm, D. and Pogue, V. and Alimohammadi, B. and Arora, P. and Herbert, L. and Cheng, J. and Dowie, D. and Mohan, S. and Peters, G. and Tuttle, K. and Albritton, S. and Benedetti, R. and Joshi, S. and Lund, B. and Shuler, L. and Trevino, M. and Mai, K. and Osborn, T. and Parekh, R. and Eustace, J. and Novak, G. and Patterson, S. and Lindsey, C. and Hill, T. and Liston, M. and Wiegmann, T. and Nagaria, A. and Hurd, C. and Hurst, A. and Omoscharka, E. and Parks, S. and Price, V. and Schouten, D. and Rashid, H. and Birtcher, K. and Cantu, J. and Tait, C. and Taun, W. and Fadem, S. and Das, D. and Khosla, U. and Brown, C. and Brown, T. and Buquing, J. and Cromwell, H. and Dickson, N. and Najimipour, B. and Robeson, J. and Tabibi, W. and Mulloy, L. and Bailey, K. and Burton, B. and Fall, P. and Jagadeesan, M. and Paulson, W. and Szerlip, H. and White, J. and Faulkner, M. and Adeleye, O. and Boatright, D. and Mensah, D. and Nwankwo, U. and Crutcher, L. and Cummings, C. and Floyd, M. and Putatunda, B. and Ross, J. and Sanford, V. and Thadani, U. and Haragsim, L. and Parker, B. and Rogan, L. and Thresher, M. and Turner, J. and Dworkin, L. and Mignano, D. and O'Mara, A. and Shemin, D. and Bakris, G. and Basta, E. and Chua, D. and Neri, G. and Ahmed, I. and Elliott, W. and Fondren, L. and Hasabou, N. and Khosla, N. and Mazin, A. and Riehle, J. and Kovesdy, C. and Mendoza, J. and Ahmadzadeh, S. and Iranmanesh, A. and Lewis, M. and Lu, J. and Benabe, J. and Gonzalez-Melendez, E. and Padilla, B. and Serrano, J. and Russ, T. and Athmann, L. and Funke, L. and Larson, P. and Roach, D. and Salveson, B. and Nogueira, J. and Hanes, D. and Hise, M. and Light, P. and Copland, E. and Fink, J. and Hakim, M. and Hough, K. and McMinn, S. and Weir, M. and Young, C. and Kershaw, G. and Hill, I. and White, B. and Plumb, T. and Florescu, M. and Groggel, G. and Martin, M. and Rao, V. and Denu-Ciocca, C. and Candiani, C. and Cooper, J. and Gordon, B. and Joy, M. and Kiser, M. and Lambeth, C. and Rosas, S. and Cochetti, P. and Robinson, J. and Schankel, K. and Teng, H. and Weise, W. and Geneidy, A. and Murray, P. and Solomon, R. and De Waal, D. and LaPointe, S. and Schoenknecht, A. and Campese, V. and Habashy, M. and Ananthakrisna, R. and Bedwani, D. and Fazli, U. and Fetrat, M. and Frampton, Q. and Kaldas, B. and Kazarian, V. and Pitts, L. and Sadeghi, A. and Yeasmin, N. and Young, E. and Fissell, R. and Belanger, K. and Ricci, N. and Farwell, W. and Bowman, T. and Dhingra, R. and Pesenson, A. and Ambrosino, J. and Chittamooru, S. and Kaufman, J. and Ramos, M. and Yap, C. and Nakhle, S. and Aligaen, L. and Duren, D. and Laine, B. and Moore, S. and Tuazon, H. and Coyne, D. and Audrain, J. and Bryant, B. and Dombek, S. and Freeman, S. and Klein, P. and Germain, M. and Berkowitz, A. and Bokhari, A. and Braden, G. and Diaz, A. and Greco, B. and Mulhern, J. and O'Shea, M. and Poindexter, A. and Poppel, D. and Ryan, M. and Sweet, S. and Ye, J. and Osterman, J. and Lin, T. and Mays, B. and Rizvi, A. and Sonnier, C. and Twining, C. and Wang, S. and Hix, M. and Schenck, J.
DOI: 10.1016/j.ahj.2010.08.012
2010Application of principal component analysis to pharmacogenomic studies in Canada.
Visscher H and Ross CJ and Dubé MP and Brown AM and Phillips MS and Carleton BC and Hayden MR
DOI: 10.1038/tpj.2009.36
PubMed: 19652663
12/2009Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.
Ross CJ and Katzov-Eckert H and Dubé MP and Brooks B and Rassekh SR and Barhdadi A and Feroz-Zada Y and Visscher H and Brown AM and Rieder MJ and Rogers PC and Phillips MS and Carleton BC and Hayden MR and CPNDS Consortium
DOI: 10.1038/ng.478
PubMed: 19898482
12/2009Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.
Carleton B and Poole R and Smith M and Leeder J and Ghannadan R and Ross C and Phillips M and Hayden M
DOI: 10.1002/pds.1772
PubMed: 19507171
08/2009Enhanced atherothrombotic formation after oxidative injury by FeCl3 to the common carotid artery in severe combined hyperlipidemic mice.
Biochemical and biophysical research communications
Xian X and Ding Y and Zhang L and Wang Y and McNutt MA and Ross C and Hayden MR and Deng X and Liu G
DOI: 10.1016/j.bbrc.2009.05.101
PubMed: 19481534
05/2009Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.
Vaessen SF and Dallinga-Thie GM and Ross CJ and Splint LJ and Castellani LW and Rensen PC and Hayden MR and Schaap FG and Kuivenhoven JA
DOI: 10.1194/jlr.m800551-jlr200
PubMed: 19141870
05/2009Presynaptic defects underlying impaired learning and memory function in lipoprotein lipase-deficient mice.
Xian X and Liu T and Yu J and Wang Y and Miao Y and Zhang J and Yu Y and Ross C and Karasinska JM and Hayden MR and Liu G and Chui D
DOI: 10.1523/jneurosci.0297-09.2009
PubMed: 19357293
04/2009Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells.
Wang Y and Sternfeld L and Yang F and Rodriguez JA and Ross C and Hayden MR and Carriere F and Liu G and Hofer W and Schulz I
DOI: 10.1136/gut.2007.146258
PubMed: 18936103
03/2009Acute hypertriglyceridemic pancreatitis during pregnancy due to homozygous lipoprotein lipase gene mutation.
Bartha I and Dinya T and Seres I and Paragh G and Ross C and Hayden MR and Biró S and Vargha G
DOI: 10.1016/j.cca.2008.10.016
PubMed: 19000906
02/2009Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.
Madadi P and Ross CJ and Hayden MR and Carleton BC and Gaedigk A and Leeder JS and Koren G
DOI: 10.1038/clpt.2008.157
PubMed: 18719619
01/2009The role of free fatty acids, pancreatic lipase and Ca+ signalling in injury of isolated acinar cells and pancreatitis model in lipoprotein lipase-deficient mice.
Yang F and Wang Y and Sternfeld L and Rodriguez JA and Ross C and Hayden MR and Carriere F and Liu G and Schulz I
DOI: 10.1111/j.1748-1716.2008.01933.x
PubMed: 18983441
01/2009Genotypic Approaches to Therapy in Children (GATC): Using information technology to improve drug safety
Studies in Health Technology and Informatics
Wong, E. and Carleton, B.C. and Wright, D.F.B. and Smith, M.A. and Verbeek, L. and Hildebrand, C.A. and Stannard, P. and Vaillancourt, R. and Elliot-Miller, P. and Ross, C.J.D. and Hayden, M.R.
DOI: 10.3233/978-1-58603-979-0-209
2009Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safety.
Wong E and Carleton BC and Wright DF and Smith MA and Verbeek L and Hildebrand CA and Stannard P and Vaillancourt R and Elliot-Miller P and Ross CJ and Hayden MR
PubMed: 19380938
2009Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients.
Stroes ES and Nierman MC and Meulenberg JJ and Franssen R and Twisk J and Henny CP and Maas MM and Zwinderman AH and Ross C and Aronica E and High KA and Levi MM and Hayden MR and Kastelein JJ and Kuivenhoven JA
DOI: 10.1161/atvbaha.108.175620
PubMed: 18802015
12/2008Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet.
Zhang X and Qi R and Xian X and Yang F and Blackstein M and Deng X and Fan J and Ross C and Karasinska J and Hayden MR and Liu G
DOI: 10.1161/circresaha.107.156554
PubMed: 18032735
02/2008Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.
Oberlander TF and Bonaguro RJ and Misri S and Papsdorf M and Ross CJ and Simpson EM
DOI: 10.1038/sj.mp.4002007
PubMed: 17519929
01/2008Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.
Ross CJ and Carleton B and Warn DG and Stenton SB and Rassekh SR and Hayden MR
DOI: 10.1196/annals.1423.020
PubMed: 17911433
09/2007Screening and assessing adolescent asthmatics for anxiety disorders.
Ross CJ and Davis TM and Hogg DY
DOI: 10.1177/1054773806295235
PubMed: 17204805
02/2007Expression of LPL in endothelial-intact artery results in lipid deposition and vascular cell adhesion molecule-1 upregulation in both LPL and ApoE-deficient mice.
Wang J and Xian X and Huang W and Chen L and Wu L and Zhu Y and Fan J and Ross C and Hayden MR and Liu G
DOI: 10.1161/01.atv.0000249683.80414.d9
PubMed: 17038632
01/2007Pharmacogenomics and its implications for autoimmune disease.
Ross CJ and Katzov H and Carleton B and Hayden MR
DOI: 10.1016/j.jaut.2007.02.008
PubMed: 17418528
2007Volumetric cartilage measurements of porcine knee at 1.5-T and 3.0-T MR imaging: evaluation of precision and accuracy.
Bauer JS and Krause SJ and Ross CJ and Krug R and Carballido-Gamio J and Ozhinsky E and Majumdar S and Link TM
DOI: 10.1148/radiol.2412051330
PubMed: 17057067
11/2006Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma.
Burgess BL and McIsaac SA and Naus KE and Chan JY and Tansley GH and Yang J and Miao F and Ross CJ and van Eck M and Hayden MR and van Nostrand W and St George-Hyslop P and Westaway D and Wellington CL
DOI: 10.1016/j.nbd.2006.06.007
PubMed: 16899370
10/2006Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation.
Rip J and Nierman MC and Ross CJ and Jukema JW and Hayden MR and Kastelein JJ and Stroes ES and Kuivenhoven JA
DOI: 10.1161/01.atv.0000219283.10832.43
PubMed: 16574898
06/2006Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
Ross CJ and Twisk J and Bakker AC and Miao F and Verbart D and Rip J and Godbey T and Dijkhuizen P and Hermens WT and Kastelein JJ and Kuivenhoven JA and Meulenberg JM and Hayden MR
DOI: 10.1089/hum.2006.17.487
PubMed: 16716106
05/2006Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia.
Zhao T and Guo J and Li H and Huang W and Xian X and Ross CJ and Hayden MR and Wen Z and Liu G
DOI: 10.1016/j.bbrc.2006.01.067
PubMed: 16460682
03/2006In response [5]
Arteriosclerosis, Thrombosis, and Vascular Biology
Ross, C.J.D. and Twisk, J. and Kuivenhoven, J.A. and Rip, J. and Kastelein, J.J. and Hayden, M.R.
DOI: 10.1161/01.ATV.0000203502.01793.8d
2006Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Rip J and Nierman MC and Sierts JA and Petersen W and Van den Oever K and Van Raalte D and Ross CJ and Hayden MR and Bakker AC and Dijkhuizen P and Hermens WT and Twisk J and Stroes E and Kastelein JJ and Kuivenhoven JA and Meulenberg JM
DOI: 10.1089/hum.2005.16.1276
PubMed: 16259561
11/2005Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation.
Ross CJ and Liu G and Kuivenhoven JA and Twisk J and Rip J and van Dop W and Excoffon KJ and Lewis SM and Kastelein JJ and Hayden MR
DOI: 10.1161/01.atv.0000176971.27302.b0
PubMed: 16002740
10/2005Cognitive-behavioral treatment combined with asthma education for adults with asthma and coexisting panic disorder.
Ross CJ and Davis TM and MacDonald GF
DOI: 10.1177/1054773804273863
PubMed: 15793272
05/2005Gene therapy provides hope for the treatment of arthritis
Clinical Genetics
Ross, C.J.D.
DOI: 10.1111/j.1399-0004.2005.0507b.x
2005Coagulating evidence for a new genetic link to drug responsiveness to warfarin therapy
Clinical Genetics
Ross, C.J.D.
DOI: 10.1111/j.1399-0004.2005.0507a.x
2005Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
Ross CJ and Twisk J and Meulenberg JM and Liu G and van den Oever K and Moraal E and Hermens WT and Rip J and Kastelein JJ and Kuivenhoven JA and Hayden MR
DOI: 10.1089/hum.2004.15.906
PubMed: 15353045
09/2004Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1.
Wellington CL and Brunham LR and Zhou S and Singaraja RR and Visscher H and Gelfer A and Ross C and James E and Liu G and Huber MT and Yang YZ and Parks RJ and Groen A and Fruchart-Najib J and Hayden MR
DOI: 10.1194/jlr.m300110-jlr200
PubMed: 12730295
08/2003Screening and assessing adult asthmatics for anxiety disorders.
Davis TM and Ross CJ and MacDonald GF
DOI: 10.1177/105477380201100206
PubMed: 11991171
05/2002Treatment of hemophilia B in mice with nonautologous somatic gene therapeutics.
Van Raamsdonk JM and Ross CJ and Potter MA and Kurachi S and Kurachi K and Stafford DW and Chang PL
DOI: 10.1067/mlc.2002.120649
PubMed: 11873243
01/2002Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain.
Ross CJ and Chang PL
DOI: 10.1163/156856202320401988
PubMed: 12463513
2002Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells.
Ross CJ and Ralph M and Chang PL
DOI: 10.1006/exnr.2000.7531
PubMed: 11085893
12/2000Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells.
Ross CJ and Bastedo L and Maier SA and Sands MS and Chang PL
DOI: 10.1089/104303400750001426
PubMed: 11044913
10/2000Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsules.
Ross CJ and Ralph M and Chang PL
DOI: 10.1089/10430349950019183
PubMed: 10022530
01/1999Encapsulation of various recombinant mammalian cell types in different alginate microcapsules.
Peirone M and Ross CJ and Hortelano G and Brash JL and Chang PL
DOI: 10.1002/(sici)1097-4636(19981215)42:43.0.co;2-x
PubMed: 9827683
12/1998A sequence-ready physical map of a region of 12q24.1.
Renault B and Hovnanian A and Bryce S and Chang JJ and Lau S and Sakuntabhai A and Monk S and Carter S and Ross CJ and Pang J and Twells R and Chamberlain S and Monaco AP and Strachan T and Kucherlapati R
DOI: 10.1006/geno.1997.4888
PubMed: 9344649
10/1997Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians
Clinical Nephrology
Hirata-Dulas, C.A.I. and Rith-Najarian, S.J. and McIntyre, M.C. and Ross, C. and Dahl, D.C. and Keane, W.F. and Kasiske, B.L.
1996 - Research
-
Canadian Pharmacogenomic Network for Drug Safety (CPNDS)
Canadian Institutes for Health Research (CIHR), Canada Foundation for Innovation (CFI), Genome British Columbia
The goal of CPNDS is to prevent adverse drug reactions (ADRs) in childhood by identifying predictive genomic markers for specific ADRs. Within five years, CPNDS intends to incorporate these markers into diagnostic tools that will be used to predict and prevent ADRs in children through specific dosing recommendations for commonly used drugs based on an individual's genetic make-up. The long-term goal for this project is to develop a user-friendly, and effective ADR monitoring tool and national database, to proactively prevent adverse drug reactions in susceptible children.
Specific projects seek to identify the key causal genetic factors of serious ADRs in children, including severe hearing loss caused by cisplatin chemotherapy; a lethal reaction to codeine in newborns and young children, anthracycline-induced heart failure, vincristine-induced peripheral neurotoxicity and drug-induced severe rash.Grants2020-2025 NRC gene therapy
2023-2028 CIHR Project Genome Editing
2022-2024 NMIN Gene Therapy Grand Challenge Award
2018-2024 Genome Canada Canadian Pharmacogenomics Network for Drug Safety ‘GO PGx’
Honours & AwardsNew Investigator Award, Canadian Institutes of Health Research
Michael Smith Foundation Scholar Award
Gene Cure Foundation Champion of Genetics Award
Research Group MembersMiguel Cordova, Postdoctoral Fellow
Bahareh Kashani
Neel Mehta, Postdoctoral Fellow
Fudan Miao
Khair Mufti, Doctoral Student
Jimmy Raack, Doctoral Student
Congratulations CIHR Spring 2023 Project Grant recipients
Congratulations to the BC Children's Hospital Research Institute (BCCHR) and Women’s Health Research Institute (WHRI) investigators and their teams who were awarded funding through the Canadian Institutes of Health Research (CIHR) Spring 2023 Project Grant competition. Our research community received around $8 million in new research grants as principal investigators or co-investigators.